1. Introduction {#s0005}
===============

Major depressive disorder (MDD) is the single greatest cause of disability and morbidity in adolescence and young adulthood ([@bb0400]), and is associated with social and academic impairment, and recurrent illness through adulthood ([@bb0055; @bb0400]). By the time a young person reaches 25 years of age the prevalence of MDD is as high as 24% ([@bb0465]), with the peak age of onset occurring between 15 and 29 years of age ([@bb0060]). Depression is also a significant contributor to mortality in this age group: it is the illness most often associated with suicide, which is the third leading cause of death for youth aged 15--24 ([@bb0090]). The fact that most first episodes of depression emerge during early adolescence (starting at puberty) through to early adulthood underscores the importance of research focusing on this age cohort. Research in youth MDD not only will allow us to better understand the etiology of depression at its onset, but will also help work towards better clinical interventions to prevent recurrent, chronic episodes.

Influential models of adolescent brain development have emphasized the importance of social (increased reward-seeking behavior and peer affiliation), neural (protracted cortical maturation of prefrontal brain areas), and hormonal (onset of puberty and subsequent rise in sex hormones) changes in contributing to the onset of adolescent depression ([@bb0085; @bb0080; @bb0205; @bb0250]). These models propose that increased reward-seeking and risk-taking behaviors that are characteristic of adolescence may be underpinned by a temporal mismatch between the development of brain networks that support emotion generation and reward-processing (e.g., striatum, amygdala), and those implicated in the cognitive regulation of emotion (e.g., prefrontal cortex). Prefrontal cortical regions supporting cognitive--affective processes such as the cognitive regulation of emotion follow a protracted course of maturation compared to subcortical regions supporting reward and emotion, with development continuing into young adulthood ([@bb0305; @bb0620]). This temporal imbalance of subcortical and cortical maturation, in conjunction with genetic and other environmental risk factors (e.g., stress) is suggested to render adolescents more vulnerable to depression. An alternative model, proposed by [@bb0145] argues that the development of the prefrontal cortex itself may contribute to adolescent-onset MDD. Specifically, it is proposed that adolescent development of the prefrontal cortex promotes decision-making with respect to complex, and often distal, social rewards. It is hypothesized that when such rewards are not achieved, this suppresses the reward system, resulting in depressive symptoms ([@bb0145]).

In parallel with a growing focus on the clinical management of depression in youth ([@bb0515]), there is an emerging research focus on the neurobiological correlates of the disorder during this age period. One such area that has shown recent promise is the application of neuroimaging to examine the neural underpinnings of youth MDD. Studies employing such techniques, in particular functional magnetic resonance imaging (fMRI), are relevant for the investigation of neural mechanisms that may contribute to the emergence of depression in youth, and for the identification of potential biomarkers that may be associated with early stages of the illness. While existing neuroimaging studies in youth MDD have been informed by structural and functional imaging studies in adult patients, there are several compelling reasons why a greater focus on younger samples is both necessary and important for expanding current neurobiological models of the disorder. For example, studies of youth populations are less confounded by factors that are associated with the natural trajectory of the illness (e.g., functional impairments) and medications. Further, as mentioned, adolescence is characterized by rapid cortical maturation (increased synaptic pruning, myelination and neuronal plasticity) of neural areas implicated in emotional perception and regulation and reward processing ([@bb0305; @bb0620; @bb0695]) that, when altered during development, may give rise to depressive pathophysiology that has distinct underlying mechanisms from those in adult-onset MDD. In addition, pubertal processes have been linked to adolescent depression, particularly for girls, where there is evidence that *early* pubertal maturation is associated with increased risk for the development of depression ([@bb0015; @bb0300]).

In light of the above discussion, recent neuroimaging studies of youth MDD employing task-based and resting-state fMRI have begun to reveal abnormalities in neural networks implicated in emotion generative (i.e., bottom-up) processes, as well as cognitive regulatory (i.e., top-down) processes. However, to date, most studies of youth MDD have examined restricted age ranges that typically end at age 18 despite the fact that neuroimaging studies of adolescent brain development have shown that maturation of prefrontal cortical brain regions continues well into early adulthood ([@bb0305; @bb0695]). A greater focus on studies of youth depression encompassing mid-adolescence through to young adulthood (i.e., up to 25 years of age) is also necessary given that the peak age of onset of the disorder coincides with this age period. The US Food and Drug Administration\'s (FDA) black-box warning about the potential use of antidepressants to precipitate suicidal behaviors also extends to this older age, suggesting that the neurobiological factors that underlie the effects distinguish youth from adults ([@bb0230]). Finally, studies examining this age cohort are clinically relevant in the context of some clinical youth mental health services, which extend their treatment programs to 25-year olds ([@bb0510; @bb0515]). Thus a systematic review is warranted that captures studies of youth MDD, spanning 13--25 years of age. To date, only one review of the adolescent MDD literature has been published ([@bb0395]). This review provided a broad overview of studies across various imaging modalities including diffusion tensor imaging (DTI), structural and functional MRI and magnetic resonance spectroscopy (MRS). In summary, it emphasized cortico-limbic alterations as being central to emotional dysregulation in adolescent MDD. However while their review focused on studies of childhood and adolescent depression, it did not explicitly focus on studies of youth MDD up to 25 years of age, or make comparisons between younger and older youth with MDD.

Therefore the aims of this article are to provide an updated, systematic review of fMRI studies in adolescent and youth MDD populations, and to directly compare findings between younger and older youth with MDD. For the reasons previously stated, we selected studies that included patients ranging from early adolescence to early adulthood (13--25 years old). We focused our review on fMRI studies, and as such, aimed to build on the [@bb0395] review by providing a more detailed description of fMRI studies and their implications. We also included task-based functional connectivity studies in youth MDD, whereas the [@bb0395] review focused only on studies employing resting-state functional connectivity. Furthermore, to provide a more comprehensive account of the literature we extended our search to encompass neuroimaging studies of adult MDD, in order to identify studies that included young samples (mean age ≤ 25 years old). To this end we identified additional four studies. One of the studies identified focused on first-episode MDD patients with a mean age slightly higher than our cut-off of 25 ([@bb0330]; see [Table 1](#t0005){ref-type="table"}). This study was included in the review.

2. Method {#s0010}
=========

2.1. Literature search {#s0015}
----------------------

A computerized search using the databases PubMED, PsycINFO and Science Direct, covering the period from January 2001 to September 2012, was conducted using the following key search terms (\* = truncated): "adolescen\* AND depress\* AND brain imaging", and advanced searches: "youth\* NEAR/5 depression AND (brain OR imaging)". January 2001 was chosen as the start date because the first neuroimaging study in adolescent MDD was published in 2001. Additional age filters were activated in PubMED to further refine the search, which included: adolescence (13--18 years) and young adulthood (19--25 years). The reference lists of articles meeting the inclusion criteria as well as recently published reviews were also searched manually for relevant articles.

2.2. Study selection {#s0020}
--------------------

Studies were included if they: (i) Utilized fMRI (task based and/or resting state); (ii) included individuals with a diagnosis of MDD using recognized diagnostic criteria such as DSM-IV ([@bb0020]) or ICD-10 ([@bb0765]); (iii) included individuals who were in the age range of early-mid adolescence (13--18), and/or young adulthood (19--25); (iv) statistically compared the MDD group to a group of healthy controls (for non-treatment studies); and (v) were published in English. Due to variability in the age parameters used to define groups across studies and 'pooling' of participants within studies across ages ranging from late childhood/early adolescence through to late adolescence (e.g., 11--18), some studies who recruited individuals as young as 8 were considered for inclusion in the current review. We did not exclude treatment studies or studies where overlapping samples (i.e., the same cohort of patients) were used, although these will be identified as such when reviewed below.

3. Results {#s0025}
==========

The literature search for fMRI studies conducted in adolescent and youth MDD yielded a total of 26 studies. Two studies were subsequently excluded as they focused on childhood MDD (8--10 years), which was outside of the focus of this review and has been reviewed elsewhere ([@bb0395]). Of the remaining 24 studies, 20 were task-based fMRI studies, two of which were treatment studies, and four were resting-state fMRI studies. Of the 20 task-based fMRI studies, 4 employed emotional processing paradigms ([@bb0520; @bb0725; @bb0730; @bb0785]), 6 employed reward-processing paradigms ([@bb0135; @bb0245; @bb0255; @bb0260; @bb0555; @bb0630]), and 5 employed cognitive-control paradigms encompassing a range of processes including selective and sustained attention, decision making and response inhibition ([@bb0095; @bb0150; @bb0335; @bb0560; @bb0780]). Five further studies examined the cognitive regulation of emotional stimuli, hereafter referred to as *affective cognition* ([@bb0045; @bb0455; @bb0460; @bb0570; @bb0615]). While the majority of the 20 task-based fMRI studies focused on the conventional assessment of brain regional activation (i.e., activity increases) and deactivation (i.e., activity decreases) in response to imaging task demands, 2 of these studies also reported on the analysis of task-based functional connectivity[1](#fn0005){ref-type="fn"}. Of the 4 resting-state functional connectivity studies[2](#fn0010){ref-type="fn"}, 3 acquired data while participant\'s eyes were closed ([@bb0140; @bb0405; @bb0410]) and one study did not specify ([@bb0125]). All of these resting-state studies were based on imaging sequences that ranged from 6 to 12 min in duration. Our broader literature search of the adult MDD literature revealed another 4 studies that included young people with first-episode MDD up to the age of 25 ([@bb0330; @bb0500; @bb0815; @bb0820]). Two of these studies reported on emotional processing paradigms ([@bb0500; @bb0815]) and 2 reported on resting state functional connectivity measures ([@bb0330; @bb0820]). The 28 studies included in our review are summarized comprehensively in [Table 1](#t0005){ref-type="table"}.

Results from the 28 identified studies will be reviewed in order of their primary domain as follows: emotional processing, cognitive control, affective cognition, reward-based decision-making, and resting-state functional connectivity. To capture the distinction between adolescent-onset MDD (i.e., 13--18 years old) and early-adulthood onset MDD (19--25), we compare commonalities and differences between studies with a mean age of \< 18 and \> 18 years old years old within each domain, where feasible. In addition, we qualitatively summarize youth findings in comparison to adult studies where the same paradigm or approach has been used. However, it was not the aim of this review to provide a comprehensive summary of the literature in adult MDD, which has been done elsewhere recently ([@bb0580; @bb0595]).

3.1. Emotion processing {#s0030}
-----------------------

Emotion dysregulation is a core feature of MDD ([@bb0020]). In an attempt to unravel the neural underpinnings of disrupted emotion processing, there have been numerous task-based fMRI studies examining emotion processing in adult MDD populations (see [@bb0710] for review). The most widely used approach for examining emotional processing in the adult and youth MDD literature has involved measuring evoked neural responses to emotional faces. Emotional faces have been widely used because they are salient, socially relevant stimuli that capture attention rapidly and are associated with robust activation in medial prefrontal regions, the amygdala, insula and visual cortical regions that are implicated in face recognition and emotion decoding ([@bb0370; @bb0750]). In addition, MDD, which is characterized by biased facial emotion processing towards negative faces, makes facial stimuli particularly relevant for studying the neurobiological correlates of the disorder (see [@bb0070] for review). Studies of MDD examining emotion processing using emotional face stimuli use tasks that target rapid, automatic (i.e., bottom-up) emotion generative processes. These tasks typically probe limbic (e.g., amygdala, hippocampal) activation ([@bb0350]). Some of these tasks are explicit; that is they require an overt response to the emotional content of the face (e.g., identifying the emotional expression of a face), while others are implicit (e.g., passive viewing or labeling the gender of a face portraying different emotional expressions).

The most commonly used paradigm in the youth MDD literature has been an adaptation of the emotional face-matching paradigm originally developed by [@bb0350]. The emotional face-matching paradigm is a well-validated task that has been shown to reliably activate the amygdala in healthy adults ([@bb0350; @bb0355]) and adolescents ([@bb0775]). Furthermore, the task has proved to be a sensitive probe of depression-related brain abnormalities, that have been further shown to predict treatment response in adults with MDD ([@bb0470]). In healthy adults and adolescents, performance of such face-matching tasks, is most consistently associated with robust amygdala activation to fearful target faces, although amygdala activation to happy and angry faces has been reported ([@bb0770; @bb0775]).

In studies of emotional processing in adolescent and youth MDD using an emotional face-matching paradigm, the most consistent finding has been that of elevated amygdala activation to threat-related (i.e., fearful, angry) faces compared to task control (e.g., shape-matching) conditions. Five of the 6 studies, which include samples with a mean age ranging from 12 to 24.5 years have reported predominantly left-sided ([@bb0520; @bb0725; @bb0785; @bb0815]), but also bilateral ([@bb0500]) elevated amygdala activity in patients compared to age and gender matched healthy controls. Furthermore, 3 of the 6 studies report a positive correlation between amygdala activation or connectivity and depression symptom severity scores ([@bb0500; @bb0520; @bb0815]). In the only imaging treatment study of youth MDD using an implicit, emotional face task where participants had to explicitly label the gender of the face, 8-week treatment with fluoxetine was associated with reduced (relative to baseline) left-sided amygdala activation in response to fearful (vs. neutral) faces, that was comparable to healthy controls ([@bb0725]). This study also reported greater bilateral orbitofrontal cortex (OFC) and subgenual anterior cingulate cortex (ACC) activation at baseline to fearful faces (vs. neutral faces) that was normalized following 8-week treatment with fluoxetine. However, this study did not ascertain whether any of the baseline imaging parameters predicted response vs. non-response.

In contrast to findings of elevated amygdala activation found across all studies of emotion processing in adolescent and youth MDD, [@bb0730] reported blunted amygdala activation to emotional (fearful) faces (vs. fixation cross) in a sample of depressed children and adolescents aged 8--16. This finding is discrepant compared to other studies conducted in similar age cohorts and may be explained by the differences in the tasks used as well as patient sample characteristics. Whereas the former studies utilized tasks that required low-level attentional responses to stimuli (i.e., forced matching by facial expression or gender), thus potentially tapping into automated or subliminal affective responding, [@bb0730] used a passive viewing task where no response was required; and rather than using a control task (i.e., neutral faces), [@bb0730] employed a fixation cross as the comparison condition. Furthermore, the small sample size of MDD patients (n = 5), inclusion of only females, and large variance in age within the MDD group in the [@bb0730] study makes direct comparisons with the other studies difficult. Collectively, however, these emotional face-matching studies provide support for altered activity in emotion processing networks in youth MDD that is specific to threat-related emotional stimuli.

Findings in studies with a mean age \> 18 are consistent with those in adolescent MDD cohorts (i.e., \< 18 years old) and have reported amygdala hyperactivity and altered subgenual ACC connectivity, for example, in line with findings of increased subgenual ACC activation in adolescent MDD during the processing of fearful faces ([@bb0725]). [@bb0500] provided evidence that altered amygdala-ACC connectivity is implicated in young adult-onset MDD. The authors used functional connectivity analyses^2^ to examine functional coupling between the bilateral extended amygdala (EA) and the ACC during performance of the face-matching task in a sample of young adults (mean age 24.5) with MDD. They reported *increased* connectivity between the bilateral EA and subgenual ACC and *attenuated* connectivity between bilateral EA and pregenual ACC during the face-matching condition (collapsed across all faces). Furthermore, a negative correlation was found between depressive symptoms, as measured by Beck Depression Inventory (BDI) scores, and connectivity between the amygdala and pregenual ACC, such that higher BDI scores (indicating greater depression severity) was associated with weaker connectivity between these two regions. These findings suggest a dysfunction of medial prefrontal cortical (PFC) network areas and interconnected limbic regions including the amygdala, which support emotional processing in youth MDD.

Collectively, the findings in emotion processing studies of youth MDD are similar to those reported in adult patients with MDD. A large number of neuroimaging studies have examined emotional processing in adult MDD utilizing emotional pictures ([@bb0010; @bb0155; @bb0735]), words ([@bb0075; @bb0195; @bb0660; @bb0655; @bb0665]) and faces ([@bb0005; @bb0130; @bb0280; @bb0290; @bb0285; @bb0295; @bb0315; @bb0640; @bb0715; @bb0720; @bb0745]). Studies employing the emotional face-matching task, implicit gender labeling tasks and passive viewing tasks have predominantly reported elevated amygdala activation to negative threatening (fearful, angry) and non-threatening (sad) faces in adult depressed patients ([@bb0130; @bb0290; @bb0565; @bb0640; @bb0715; @bb0720; @bb0745]).

Consistent with functional connectivity findings in adolescent MDD, [@bb0100] reported reduced left-sided amygdala connectivity with the ACC during an implicit face processing task in adults with MDD that increased (normalized) following 8-week treatment with fluoxetine. In a movement towards identifying imaging biomarkers of treatment response using emotional processing paradigms, adult studies have shown that pre-treatment response in areas of the extended medial network including the amygdala and ACC may represent biomarkers of treatment response to cognitive behavioral therapy (CBT) ([@bb0295; @bb0655]). For example, greater pregenual ACC deactivation to sad facial expressions at baseline (i.e., pre-treatment) predicted better CBT response in a sample of depressed adults ([@bb0295]). Similarly, greater pre-treatment amygdala activation and pregenual ACC deactivation during the processing of negative words in a self-referential context predicted better CBT response in a depressed cohort ([@bb0655]).In summary, the reviewed studies demonstrate consistent evidence of hyperactivity in the amygdala and altered connectivity between the amygdala and ACC during emotional processing of negative facial stimuli in youth (both adolescent and young adult-onset) MDD. These findings, which appear to be evident during evaluative and encoding processes, are the most consistent for fearful faces, although the specificity of these findings to threat-related negative emotion vs. non-threat-related emotions (e.g., sadness) has not been evaluated. Further, there is emerging evidence that abnormal activity in these areas and the OFC, invoked by emotional stimuli, can be normalized following treatment with antidepressant medication ([@bb0725]). These findings, particularly of elevated amygdala activation have also been found in adolescents at-risk for MDD ([@bb0525]), which suggests that increase in amygdala activity may represent a neurobiological marker for MDD vulnerability. Importantly, the findings are consistent with models of adolescent MDD that emphasize the rapid development and hyperactivity of limbic networks (i.e., amygdala, hippocampus) supporting emotion generation, and concurrent inefficient cognitive networks, in contributing to the onset of psychopathology ([@bb0205]). However, across all the reviewed studies, only emotional faces were used and thus the findings are not generalizable to other relevant stimuli for studying emotional processing in MDD. Future studies are needed to determine how specific these findings are to the processing of emotional faces by using, for example, emotional stimuli such as pictures and words. Further, in addition to accumulating evidence for the role of the amygdala in depression, abnormal amygdala activity is implicated in many psychiatric disorders, in particular anxiety disorders (see [@bb0210] for review). The amygdala is a part of a interoceptive network in which the insula plays a primary role, that mediates awareness about perceived bodily arousal states (e.g., sympathetic arousal) ([@bb0105]) and activity in these regions has been shown to correlate with physiological measures of autonomic arousal ([@bb0115; @bb0110; @bb0215]). Given the highly co-morbid prevalence of anxiety disorders in young people with MDD (see [Table 1](#t0005){ref-type="table"}), future studies combining fMRI with psychophysiology-based measurements of autonomic arousal (e.g., respiration, electrodermal activity, heart rate variability) will help further delineate the role of the amygdala in moderating anxiety in youth MDD.

3.2. Cognitive control {#s0035}
----------------------

In line with early neuropsychological studies of MDD that demonstrated pronounced deficits in a range of cognitive domains (for review, see [@bb0030]), a large body of research has focused on the neural correlates of cognitive control in MDD (for review, see [@bb0170]). These studies have traditionally employed tasks that examine "cold" (i.e., non-emotional) cognitive control processes, encompassing working memory, selective and sustained attention, response inhibition, attentional set-shifting/cognitive flexibility, motor inhibition and verbal fluency. Through experimenter manipulation of task difficulty, these studies have revealed subtle deficits in cognitive performance in patients with MDD. Studying cognitive control processes in youth MDD is particularly important for understanding the neural mechanisms associated with disrupted cognitive control present in the early stages (i.e., the first-episode) of the illness.

Neuroimaging studies examining "cold" cognitive control processes in youth MDD have examined a range of processes using a diverse range of tasks that predominantly capture selective and sustained attention (e.g., Simon task), response inhibition (e.g., Go/No-Go task, multi-source interference task; MSIT, Stop Signal task) or both of these cognitive processes (e.g., continuous performance task; CPT). These tasks are generally designed to probe fronto-cingulate and parieto-temporal lobe areas, as well as basal-ganglia regions implicated in executive control processes. They are associated with robust activation in medial and superior frontal cortices, inferior parietal cortex and basal ganglia regions in healthy controls ([@bb0025; @bb0620; @bb0670; @bb0680]).

Five studies to date have examined such cognitive control processes in youth MDD ([@bb0095; @bb0150; @bb0335; @bb0560; @bb0780]). Of note, 4 of these studies were conducted in adolescents (age range 13--18), while one study focused on mid-adolescence to young adulthood (age range 15--24) ([@bb0150]). Collectively, these studies have reported mixed results. Some studies have reported robust widespread reductions in activation of fronto-cingulate regions subserving cognitive control and performance monitoring including dorsolateral (DLPFC; BA 9/46) and ventrolateral (VLPFC; BA 45/47) divisions of the PFC and dorsal ACC (24/32) in depressed youths. These findings have been obtained during tasks of sustained attention (CPT), attentional set-shifting and performance monitoring (Switch task) ([@bb0095; @bb0335]). In contrast, during tasks of response inhibition, studies have reported no significant activation differences in lateral divisions of the PFC, but have reported differences in anterior cingulate activation between depressed youth and controls. For example, during the performance of a Go/No-Go ([@bb0560]) and Stop Signal task ([@bb0780]), depressed adolescents demonstrated elevated ACC activation (BA 32) and subgenual ACC activation (BA 25) during response inhibition, with no reported differences in lateral divisions of the PFC during these tasks.

In a recent study conducted in a slighter older sample of depressed youths, [@bb0150] examined deactivation and functional connectivity of the subgenual ACC during response inhibition using the MSIT. Depressed adolescents, compared to healthy peers, demonstrated increased connectivity between the subgenual ACC and ventromedial PFC (BA 10) during *rest* compared to task-performance (rest \> response inhibition). Moreover, the magnitude of this connectivity predicted the corresponding task-related fronto-parietal activation during the task. These findings, which occurred in the absence of behavioral performance and between-group activation differences, corroborate the available findings of fronto-cingulate abnormalities during executive--attentional control processes in younger samples of depressed adolescents ([@bb0095; @bb0780]).

Direct comparisons to adult studies that have examined selective and sustained attention, attentional set-shifting and response inhibition are made difficult by the different paradigms used, and so a broader discussion is provided here. Neuroimaging studies of adult MDD have explored a more diverse range of executive functions including working memory, verbal fluency, response inhibition, motor inhibition, planning, sustained attention and attentional set-shifting. These studies are somewhat consistent with the youth MDD literature implicating deficits in similar areas; specifically the lateral PFC and ACC, although the directionality of the findings is not always consistent. Studies in adult patients examining cognitive control with a wide range of tasks including the Stroop task, Go/No-Go, CPT and working memory tasks report on predominantly reduced left-sided DLPFC activation with some evidence of reduced bilateral VLPFC and ACC activation, although elevated activation in these regions (compared to controls) has also been reported ([@bb0185; @bb0235; @bb0365; @bb0375; @bb0390; @bb0450; @bb0550; @bb0665; @bb0755]). In contrast to the adult MDD literature, where elevated activity in DLPFC, VLPFC and dorsal ACC in MDD patients have emerged when behavioral performance is matched to healthy controls (e.g., [@bb0365; @bb0495; @bb0755]), the same does not appear to be true for youth MDD. That is, of the five studies examining cognitive control in youth MDD, all reported equal behavioral performance on the cognitive tasks in the absence of elevated PFC activation, with no associations between neural activity and performance. Thus, unlike in studies of adult MDD where observations of elevated fronto-cingulate activation during matched task performance have been suggested to reflect a compensatory response or failure to deactivate as cognitive load increases, this argument cannot be made for studies of youth MDD.

In summary, the available literature in youth MDD is inconsistent. There is some evidence for altered fronto-cingulate activation, and this has been found in adolescent samples (13--18 years old). Only one study has examined functional connectivity, and this was in a slightly older depressed sample ([@bb0150]). The findings however, of reduced fronto-cingulate connectivity during cognitive control processes are consistent with the findings of reduced functional activation in frontal regions in depressed adolescents (i.e., mean age \< 18 years old). Collectively, these studies, which predominantly implicate lateral divisions of the prefrontal cortex, namely DLPFC and VLPFC, and medial network areas including the ACC, are in line with neurobiological models of adult MDD ([@bb0505; @bb0580; @bb0595; @bb0600]). These models propose that abnormalities in fronto-cingulate and fronto-parietal regions supporting higher-order (top-down) cognitive control processes result in the clinical phenomenology of impaired concentration, sustained attention and increased distractibility. However, the directionality and laterality of the findings have not been consistent with findings in adult MDD. Given that cortical maturation of prefrontal regions supporting cognitive control processes lags behind in adolescence, and continues to develop into the mid-twenties, it is not surprising that inconsistencies arise when comparisons are made to the adult MDD literature. Furthermore, cognitive deficits emerge and become more severe with recurrent MDD and are more pronounced in late-onset MDD patients compared to patients who have their first episode of illness in adolescence or early adulthood ([@bb0065]). Future longitudinal studies of youth MDD are needed to map brain activity subserving cognitive control, over time, to better understand the trajectory of cognitive control deficits in youth MDD.

3.3. Affective cognition {#s0040}
------------------------

More recently there has been a shift in the affective neuroscience literature that emphasizes the importance of examining neural systems at the *interface* of cognition and emotion, including the higher-order cognitive control of emotion. This burgeoning area of research referred to as *affective cognition* has important implications for understanding the pathophysiology of MDD which is characterized by increased susceptibility to emotional distraction ([@bb0220; @bb0415; @bb0760]) and impaired abilities to regulate emotional processing using cognitive strategies such as cognitive reappraisal ([@bb0035; @bb0175; @bb0240]). These two sub-processes of affective-cognition: emotional distraction by cognition, and cognitive regulation of emotion, despite their similarities, can be analyzed as distinct sub-processes using different paradigms. Emotional distraction has often been examined in adult MDD using tasks of response inhibition and selective attention with an added emotional component: for example the Emotional Go/No-Go task, Emotional Stroop task, and Emotional Odd-ball task ([@bb0165; @bb0190; @bb0225; @bb0415; @bb0760]). The cognitive regulation of emotion is often assessed using tasks that require participants to cognitively re-evaluate an emotional stimulus (e.g., film clip, picture, autobiographical script) in order to make it less negative, using cognitive reappraisal strategies ([@bb0035; @bb0415; @bb0540]). The study of the cognitive control of emotion, in particular cognitive reappraisal is very relevant to youth MDD because cognitive regulatory strategies such as reappraisal are a key component of CBT, the first-line recommended treatment for young people with MDD.

The most commonly used paradigm for examining neural activity associated with affective cognition in youth MDD has been an emotion--attention interference task. This task, which assesses the effects of emotional stimuli on the ability to perform a cognitive task, requires participants to view emotional faces (fearful, angry, happy) while under varying attentional conditions ([@bb0045; @bb0455; @bb0460; @bb0615]). Of note, the passive viewing condition, which measures implicit emotion perception is similar to and can be compared with studies of emotional processing in youth MDD (reviewed above) as it measures emotion recognition and perception and does not require overt cognitive processes. Examining neural activity during the 3 constrained attention conditions of this task allows for the separate analysis of the attentional control of emotion as compared to baseline emotional processing (passive viewing condition).

Five studies have examined affective cognition in youth MDD. Four of these studies, using over-lapping samples (i.e., some of the same patients) (see [Table 1](#t0005){ref-type="table"}), have used the emotion--attention interference task described above. These studies, which have focused on samples encompassing late childhood to late adolescence (9--18) have all reported elevated amygdala activation in depressed youths compared to controls, during the viewing of fearful faces when attention was focused on internally experienced fear ("How afraid are you of this face?" "How hostile is this face?") ([@bb0045; @bb0455; @bb0460]) with weaker evidence of amygdala activation for happy faces. Incorporating a memory component to the emotion--attention task to assess the effects of emotional distracter stimuli on memory encoding, [@bb0615] compared neural activation during exposure to faces subsequently remembered to those that were forgotten. They found that although depressed patients performed the task more poorly overall, they displayed elevated left-sided amygdala activation to faces that were subsequently encoded vs. those that were not encoded, regardless of the emotional-valence (fearful, happy, angry and neutral).

One recent preliminary study ([@bb0570]) examined cognitive reappraisal in a small sample of 14 adolescents with MDD using a well-validated paradigm developed by [@bb0540; @bb0545]. In this task participants are presented with negative pictures of people or scenes (e.g., a terminally ill woman in a hospital bed) and are instructed to either react naturally to the emotional content of the picture without altering their response ("Maintain") or to reinterpret the picture ("Reappraise") so that it no longer elicits a negative response. Although no significant between-group differences were found during the reappraisal of negative images (reappraise \> maintain condition), the study reported increased amygdala activity but *decreased* connectivity with medial PFC and insula regions during the maintenance of negative affect in MDD patients. Despite the lack of significant findings during cognitive reappraisal, the authors interpreted their findings of reduced amygdala--medial PFC and amygdala--insula connectivity during the viewing of negative emotional stimuli ("maintain" condition) to reflect inefficient regulation of the amygdala by the medial PFC and poor integration of emotional responses into the insula for interoceptive awareness. The preliminary results of this study provide some support for an altered extended medial PFC network including the amygdala in youth MDD, although these findings require replication.

Studies of affective cognition in adult MDD are not very consistent with those studies in youth MDD ([@bb0165; @bb0190; @bb0225; @bb0415; @bb0760]), although the paradigms used have been quite different. These studies have used tasks including the Emotional Go/No-Go task, Emotional Stroop task, and Emotional Odd-ball task, which tap into neural regions that are implicated in maintaining goal-directed behavior (i.e., performance) during the presence of emotional distracter stimuli. These studies have reported altered (predominantly reduced) lateral PFC (DLPFC, inferior frontal gyrus), and medial PFC (ventromedial PFC, ACC and posterior cingulate) activation in depressed patients. In a similar paradigm to that reported in [@bb0615], [@bb0345] reported that depressed adults showed an enhanced amygdala response to negative but not positive emotional pictures that were subsequently remembered compared to those that were not. In addition, the authors reported increased right-sided amygdala connectivity with the hippocampus and putamen that correlated positively with depression severity. These findings, which are only partly consistent with those of [@bb0615], who found enhanced amygdala response to all emotion types, support a role for the amygdala in the enhanced encoding and memory of emotional material, particularly of negative valence, in depression, and provide further evidence for a link between enhanced memory of negative emotional stimuli in MDD, and illness severity. Studies of cognitive reappraisal in adult patients provide more compelling evidence of altered activation in neural regions supporting cognitive reappraisal. In contrast to [@bb0570], who did not find any group differences during reappraisal of negative images (vs. passive viewing), studies in adult patients consistently report on predominantly elevated activation in lateral PFC (BA 45/47), and medial PFC regions during the cognitive reappraisal of negative stimuli compared to healthy controls ([@bb0035; @bb0200; @bb0415; @bb0645]).

In summary, studies examining affective cognition in youth MDD have shown consistent evidence of elevated amygdala activation during tasks when information needs to be ignored or suppressed. Further, there is some preliminary evidence of altered medial PFC-limbic connectivity during the maintenance of negative affect in youth MDD ([@bb0570]). Overall, the literature in youth MDD is not consistent with findings in adult MDD. As with studies of emotion processing, all of these studies included patients who were medication-free, thus allowing for the examination of biological abnormalities without the confounding effects of medication. However, no study to date has examined the effects of pubertal maturation on the activity of brain regions implicated in cognitive--affective processes in youth MDD. This is a significant omission given that: i) pubertal processes are linked to depression, particularly in girls ([@bb0015; @bb0300]); ii) there is some evidence to suggest that emotion regulation processes mediate the link between pubertal maturation and depression ([@bb0120]) and; iii) emotion regulation processes are fundamental to CBT, the first-line recommended treatment for young people with MDD ([@bb0040]). These studies will have important implications for future CBT-focused studies in adolescents and young adults with MDD, and will help create a more comprehensive model of youth MDD.

3.4. Reward processing {#s0045}
----------------------

The examination of brain function related to positive affect in MDD, in particular *reward processing*, is important for identifying abnormalities in reward-related brain regions that may be associated with key affective and motivational features of MDD (e.g., anhedonia). Studying reward processing in adolescence is particularly important because adolescence is characterized by rapid development of subcortical areas implicated in reward processing (e.g., striatum, nucleus accumbens) ([@bb0620]), and is associated with social changes including increased peer affiliation and reward-seeking behavior in social contexts, that may contribute to the onset of MDD ([@bb0145; @bb0205; @bb0530]). In light of this, studies have examined the mechanisms of reward processing in adolescent MDD by using tasks that allow for the analysis of reward selection, anticipation and consummatory (outcome) phases of reward to capture the complex decision-making processes underlying real-world reward processing and positive-affect.

Reward processing in youth MDD has traditionally been studied in the context of decision-making about monetary rewards ([@bb0245; @bb0255; @bb0260; @bb0555; @bb0630]), although one recent study has examined reward processing in the context of social feedback ([@bb0135]). The most widely used tasks in the youth MDD literature have been monetary card-guessing tasks ([@bb0245; @bb0255; @bb0260; @bb0555]). These tasks are used to capture the anticipation and consummatory phases of reward and probe underlying reward-related brain areas implicated in these processes including the ventral striatum, OFC, medial PFC including the ACC, and closely connected regions including the amygdala. In these studies, the card-guessing task typically involves 3 phases: a decision making, anticipation and reward outcome phase, although the decision-making and anticipation phases are usually analyzed together. The monetary card-guessing task has been shown to reliably activate the dorsal and ventral striatum and is a sensitive measure of differential striatal responses to reward and punishment in young, healthy adults ([@bb0160]) and adolescents ([@bb0255]). Another task that has recently been used in the youth literature and is commonly used in the adult literature, is a 2-choice monetary Wheel of Fortune (WOF) task ([@bb0630], see [Table 1](#t0005){ref-type="table"}). The WOF task differs from card guessing tasks as it involves participants choosing from 2 monetary wheels that contain varying probabilities of winning money (25/75% wheel, 50/50% wheel) with small (\$2 or \$1) and large (\$6 or \$3) magnitudes. Unlike card-guessing tasks, the WOF task allows for the separate examination of reward *selection*, independent of anticipation and feedback.

Of the 6 studies examining reward processing in youth MDD, 5 have utilized monetary reward tasks ([@bb0245; @bb0255; @bb0260; @bb0555; @bb0630]) and, as mentioned, 1 study examined *social* rewards in the context of positive feedback ([@bb0135]). These studies have most consistently reported diminished striatal activation during reward anticipation and outcome in depressed youth versus healthy controls ([@bb0245; @bb0255; @bb0260]). These effects appear to persist following positive feedback (i.e., a win in the previous trial) ([@bb0555]) and are associated with lower self-reported positive affect ([@bb0255]). Findings have been bilateral and localized predominantly to the caudate (head and body). There is also evidence for diminished activation in the ACC and altered activation in the OFC and amygdala during reward anticipation and outcome. Additionally, there is some evidence that the directionality of OFC activation is dependent on the probability (high vs. low risk) and magnitude (small vs. large) of the reward outcome ([@bb0245]). Specifically, in a study utilizing a monetary guessing task where participants were required to make choices about possible rewards with varying probabilities and magnitudes, depressed adolescents showed *attenuated* activation in bilateral inferior OFC compared to controls during reward anticipation, particularly when the magnitude of the reward was high. Conversely, they showed *elevated* bilateral middle and superior OFC activation compared to controls during reward anticipation, particularly when the magnitude of reward was low. During the outcome phase, depressed adolescents demonstrated blunted OFC activation particularly following a loss and low-magnitude reward; however following a high magnitude win, depressed adolescents demonstrated elevated left-sided inferior OFC activation.

Directly comparing findings in adolescent-onset MDD studies with studies in early-adulthood MDD onset using reward-based monetary paradigms shows similarities. In particular, findings of differential OFC responses to probability and outcome of reward mentioned above have also been shown in a study employing the WOF task in a sample of 18--22 year olds ([@bb0630], see [Table 1](#t0005){ref-type="table"}). Similarly, in a study of 15--24 year olds with MDD utilizing a social feedback task, hyperactivity of the amygdala was reported during positive feedback---a finding consistent with amygdala hyperactivation to large wins in monetary card-guessing tasks in younger (i.e., adolescent-onset) MDD patients ([@bb0245]). Finally, there is some evidence that pre-treatment striatal and mPFC activity during reward processing may be a valid predictor of treatment response to psychotherapy and medication in adolescents with MDD ([@bb0260]), although this finding has not been replicated in older (\> 18 years old) cohorts.

In the only study to examine gender and pubertal development as moderators of neural activation during reward processing and depressive symptoms, greater activity in mPFC including medial frontal gyrus (BA 10) and anterior cingulate (BA 32) during reward outcome was associated with increased depressive symptoms in boys two years later. An important finding of the study was that reduced caudate activation during reward anticipation predicted increases in depressive symptoms that were specific to adolescents in mid-late puberty ([@bb0530]).

Studies in adult depressed patients employing monetary reward ([@bb0165; @bb0590; @bb0690; @bb0705]), and positive feedback tasks ([@bb0700]) are largely consistent with findings in youth MDD. These studies have most consistently reported blunted caudate and putamen activation during reward selection, anticipation and outcome ([@bb0590; @bb0685; @bb0690; @bb0705]), and following positive feedback ('win') in a card-guessing task ([@bb0700]). However activation in the caudate has been more localized to the ventral caudate/nucleus accumbens in studies of adult MDD. Further, imaging treatment studies provide some evidence for a state-related abnormality of the ventral striatum. For example, pre-treatment hypoactivity of the ventral striatum associated with the anticipation of gain and loss during a Monetary Incentive Delay (MID) task was normalized following 6-week treatment with the SSRI citalopram ([@bb0705]). Similarly, in a treatment study examining the therapeutic effects of behavioral activation (a form of psychotherapy) on neural responses to reward anticipation and feedback during the WOF task, MDD patients exhibited increased activation in the left caudate nucleus during reward anticipation following treatment ([@bb0165]). The authors interpreted these findings as reflecting increased mesolimbic functioning (i.e., antidepressant-induced changes of dopamine neurotransmission), and, at the behavioral level, increased motivation and goal-directed behavior in the context of anticipating rewards. In parallel with observations of reduced striatal activity, some studies have reported on medial PFC hyperactivity during reward processing in adult MDD ([@bb0425; @bb0435; @bb0685]). Using a MID task, [@bb0435] reported increased dorsal ACC activation that was associated with increasing gain during reward anticipation. Using the WOF task, [@bb0685] reported elevated OFC activation during reward selection, although the finding of increased ACC activation was not replicated.

In summary, studies of youth MDD have utilized robust paradigms that allow for the examination of reward processing in the context of monetary rewards, but also social feedback. These studies have consistently found blunted striatal activation and altered OFC activation during risky-decision making about monetary rewards, and following reward outcome. These findings, coupled with observations of elevated activity in other ventromedial PFC regions including medial frontal gyrus (BA 10) ([@bb0255]) and limbic regions including the amygdala ([@bb0135]) during positive feedback, suggest abnormal reward processing in young people with MDD, that may be driven by: i) a diminished striatal response to reward (during anticipation and outcome); and concurrently ii) an 'over-active' medial PFC system. Furthermore, there is growing evidence that mPFC activation moderates treatment response differently in females and males, and may serve as a predictive neural biomarker in youth MDD. An interesting finding amongst these studies is that functional activation reported in the caudate was predominantly localized to the head and body (dorsal division) of the caudate. Given the well-established role of the *ventral* striatum in reward processing and reward-based decision-making, one might have expected differences in functional activity to be localized to the nucleus accumbens, which is situated at the ventral portion of the head of the caudate. Differences in the anatomical localization of findings in the caudate (i.e., dorsal vs. ventral) may have relevant implications for understanding the pathophysiology of the disorder and should be considered in future studies. Finally, there is emerging evidence that suggests gender and puberty moderate neural responses to reward and interact to predict depressive symptoms differently in boys and girls ([@bb0530]). In order to provide a more comprehensive neurobiological model of adolescent MDD, it will be important to tease apart the effects of pubertal stage vs. pubertal timing, on brain function in adolescent MDD.

3.5. Resting-state studies {#s0050}
--------------------------

Recent advances in the application of brain imaging to study psychiatric disorders have lead to examining alterations in the organization and connectivity of brain networks ([@bb0265]). One such approach, namely resting-state functional connectivity, allows for the examination of spontaneous fluctuations of the BOLD signal (\~ 0.04 Hz) that occur during resting conditions across spatially distributed brain regions ([@bb0275; @bb0360]). Functional connectivity-based MRI has been used to localize functional connectivity abnormalities across a range of psychiatric disorders, and to identify connectivity patterns that predict treatment response, as well as clinical measures of illness severity ([@bb0270; @bb0340; @bb0650; @bb0805]). In addition, functional connectivity-based methods offer an attractive framework for studying psychiatric disorders due to their practical benefits including minimal demands on patient compliance and short acquisition times. Further, the highly replicable nature of resting-state fMRI measurements within and across subjects makes the technique potentially more universally comparable ([@bb0635; @bb0740]).

In light of this, 6 studies have examined resting-state functional connectivity in youth with MDD ([@bb0125; @bb0140; @bb0330; @bb0405; @bb0410; @bb0820]). Some of these studies have been in adolescent onset MDD ([@bb0125; @bb0405; @bb0410; @bb0820]) while others have focused on early adult-onset MDD ([@bb0140; @bb0330]). These studies have used a range of methods to measure functional connectivity including seed-based correlations, graph theory analysis (GTA) and independent component analysis (ICA) ([@bb0125; @bb0140; @bb0410; @bb0820]) (see [Table 1](#t0005){ref-type="table"} and [@bb0485] for review). For analysis of resting-state activity, studies have used complimentary methods that quantify the magnitude of fluctuations in the BOLD signal. These methods have been based on amplitude of low-frequency fluctuation (ALFF) ([@bb0405]) and regional homogeneity (ReHo) ([@bb0330]) approaches (see [Table 1](#t0005){ref-type="table"} for a description of resting-state measures).

These studies consistently implicate abnormally increased resting-state functional connectivity in medial PFC areas including the pregenual ACC (most consistently BA 32) and subgenual (BA 25) ACC, and dorsomedial (BA 8) and ventromedial (BA 10) divisions of the PFC in adolescent and youth MDD ([@bb0125; @bb0140; @bb0405; @bb0410; @bb0820]). Of note, these medial PFC areas are also components of the default mode network (DMN), a network of brain regions that exhibit elevated activity during rest and become *deactivated* during goal-directed behavior (i.e., during task performance). DMN activity is thought in part to reflect self-referential processing ([@bb0325; @bb0610; @bb0645; @bb0710]), and as such, failure to deactivate DMN areas during tasks requiring cognitive engagement is thought to reflect an 'inability' to disengage from self-related thought processes.

In a recent study [@bb0140] performed a seed-based functional connectivity analysis in a sample of 18 depressed adolescents and 19 controls using seeds in sub-regions of the ACC, namely subgenual ACC, pregenual ACC, and anterior and posterior mid-cingulate cortices. The authors reported that depressed adolescents demonstrated increased functional connectivity between i) the subgenual ACC and dorsomedial PFC and ii) the pregenual ACC and left DLPFC. Further, the magnitude of the subgenual ACC-dorsomedial PFC connectivity difference significantly predicted patients\' illness severity, which was stronger for unmedicated patients. This finding of increased functional connectivity between subgenual ACC and dorsomedial PFC and relationship to illness severity, adds to a growing body of literature demonstrating the prognostic utility of fMRI in predicting illness severity and treatment response based on measures of cingulate activity and connectivity, which is particularly robust for the pregenual ACC ([@bb0430; @bb0585]). The findings are also supported by other resting state functional connectivity studies in adolescent MDD utilizing different connectivity techniques (also see [@bb0150] in "cognitive control" section above). For example, in a recent study utilizing ICA to identify and analyze the DMN in a larger group of depressed young adults (n = 32) and healthy controls (n = 33), young depressed adults showed increased functional connectivity in the dorsomedial PFC extending into ventral ACC (BA 9 to 24/32), and ventromedial PFC (BA 10/11) ([@bb0820]), that correlated with self-report measures of rumination. Indirect support for this pattern of connectivity findings comes from another study which utilized GTA in depressed adolescents and healthy controls and reported overall reduced connectivity across networks in the brain, but increased connectivity within bilateral ACC, dorsolateral and medial PFC, as well as amygdala and temporal cortices ([@bb0410]). The findings from this study, which were in a younger sample of depressed patients (age range 15--18 years old), implicate overlapping regions as those reported in [@bb0140]. Taken together, these findings are compelling because they were derived using different methodological approaches and in slightly different age groups (mean age \< 18 and \> 18 years old respectively), but implicate similar neural regions that are disturbed in youth MDD.

Emerging findings from resting-state studies in adult MDD are largely consistent with the youth findings, and provide support for altered resting-state activity and connectivity in DMN regions, with some evidence for associations with symptom profiles ([@bb0320; @bb0340; @bb0475; @bb0650; @bb0790; @bb0800; @bb0810]). Three studies have demonstrated increased functional connectivity between the subgenual ACC and dorsomedial PFC using seed-based analyses ([@bb0340; @bb0650]) and ICA ([@bb0320]), lending further support for the view of an altered medial PFC network in MDD, in which the ACC is a 'hub'. The finding of increased pregenual ACC-left dorsolateral PFC connectivity in youth MDD has not previously been reported in adult MDD but suggests that the DLPFC may be a potential candidate for future fMRI biomarker research. Further research is needed to test whether this is an abnormality specific to youth MDD.

In summary, resting state functional connectivity abnormalities in DMN areas, particularly implicating subgenual ACC, dorsomedial and ventromedial PFC, have been reported in youth MDD. These findings, which have been found in medicated and unmedicated patients and across wide age ranges spanning mid adolescence into early adulthood, also correlate with distinct symptom profiles such as rumination and illness severity. The findings, which are in alignment with resting-state abnormalities in DMN regions (including the ACC and dorsomedial PFC) in older adult MDD patients, support recent models of depression, that emphasize the importance of medial network disturbances in contributing to the clinical manifestation of disrupted visceromotor and self-referential processes including depressive rumination. Given the substantial evidence of disrupted subgenual ACC activity in MDD, and its clinical importance as a target site for deep brain stimulation (DBS) (see [@bb0180] for review; [@bb0380]), future studies examining the treatment implications of this region in youth populations holds as a promising avenue of research.

4. Supplementary quantitative analysis {#s0055}
======================================

To compliment our qualitative, systematic review, we conducted a quantitative analysis of the 28 reviewed studies. Indices of effect sizes (indexed by z-scores) for the 7 main neural regions implicated in youth MDD across the 5 reviewed primary domains, can be found in [Inline Supplementary Table S1](#b0005){ref-type="boxed-text"} (supplementary material). These 7 neural regions are discussed below and are also shown in [Fig. 1](#f0005){ref-type="fig"}. Overall, our analysis indicates that across all domains, functional differences between depressed and non-depressed youth are most robust in the ventromedial PFC (including the OFC) and amygdala, indexed by the highest z-scores across the 5 reviewed domains (maximum z score = 5.4 and 4.0, respectively). While evidence for the ventromedial PFC appears to be bilateral, there is stronger evidence for a role of the *left* amygdala in youth MDD. The DLPFC, which was most consistently implicated in the cognitive control and resting-state domains, also showed robust bilateral z-scores (maximum z score = 4.8). Overall, studies in older youths (i.e., mean age \> 18 years old) had slightly higher z-scores than studies in samples with a mean age \< 18 years old.

To compliment our qualitative, systematic review, we conducted a quantitative analysis of the 28 reviewed studies. Indices of effect sizes (indexed by z-scores) for the 7 main neural regions implicated in youth MDD across the 5 reviewed primary domains, can be found in Inline Supplementary Table S1 (supplementary material). These 7 neural regions are discussed below and are also shown in [Fig. 1](#f0005){ref-type="fig"}. Overall, our analysis indicates that across all domains, functional differences between depressed and non-depressed youth are most robust in the ventromedial PFC (including the OFC) and amygdala, indexed by the highest z-scores across the 5 reviewed domains (maximum z score = 5.4 and 4.0, respectively). While evidence for the ventromedial PFC appears to be bilateral, there is stronger evidence for a role of the *left* amygdala in youth MDD. The DLPFC, which was most consistently implicated in the cognitive control and resting-state domains, also showed robust bilateral z-scores (maximum z score = 4.8). Overall, studies in older youths (i.e., mean age \> 18 years old) had slightly higher z-scores than studies in samples with a mean age \< 18 years old.

Inline Supplementary Table S1Table S1Frequencies (%) and z-scores of the 7 neural regions most consistently implicated in youth MDD. Shown are the frequencies of which each region was implicated across the 5 primary domains, and the corresponding z-score for the reported activation/connectivity in the region, for each study.Anterior (pregenual) cingulateSubgenual cingulate cortexVentromedial PFC incl. lateral and medial OFCDorsomedial PFCDLPFCAmygdalaStriatumEmotion processing33% (2, 3)\
^3^**z** **= 3.26** (bilateral)33% (2, 6)\
^6^Baseline **z = 3.18** (bilateral) week 8 **z = 2.01** (R)[a](#tf0005){ref-type="table-fn"}16% (6)\
^6^Baseline **z = 3.85** (bilateral) week 8 **z = 2.18** (R)[a](#tf0005){ref-type="table-fn"}0%33% (4, 5)\
^4^**z = 3.41** (L BA 47) **z = 3.06** (L BA 8)\
**^5^z = 3.44** (R BA 9)100% (1, 2, 3, 4, 5, 6)\
**^3^z = 2.67** (L)[a](#tf0005){ref-type="table-fn"}\
**^4^z = 3.06** (L)\
**^5^z = 3.52** (L)\
^6^Baseline **z = 2.58** (bilateral), week0%Cognitive control40% (9, 10)\
^9^**z = 2.64** (R)\
^10^**z = 2.87** (R)40% (8, 11)\
^8^**z = 3.50** (L)\
^11^Connectivity with medial frontal gyrus (BA 10) **z = 3.95** (bilateral)40% (8, 11)\
^8^**z = 3.46** (L)\
^11^Connectivity with subgenual cingulate cortex **z = 3.95** (bilateral)0%40% (7, 10)\
^7^Simon task **z = 2.45** (R DLPFC/IFG)\
Stop task **z = 2.40** (R DLPFC BA 9/46)\
^10^**z = 2.87** (R IFC)0%40% (10, 11)\
^10^**z = 2.87** (R)\
^11^Connectivity with subgenual ACC **z = 3.4** (R)Affective cognition0%0%40% (12, 13)\
^12^**z = 3.90**[b](#tf0010){ref-type="table-fn"} (R)\
^13^**z = 1.77** (L) (trend effect only when MDD with comorbid anxiety was included)0%20% (12)\
^12^**z = 3.69** (bilateral DLPFC/BA 9)100% (12, 13, 14, 15, 16)\
^12^**z = 4.0** (L)\
^13^Hyperactivity to fearful faces in MDD with and without comorbid anxiety: **z = 3.08** (L) and **z = 3.05** (L) respectively. Deactivation to passive fearful vs. happy faces in MDD with and comorbid anxiety: **z = − 2.15** (L) and **z = − 2.34** (L) respectively\
^14^Fearful faces: MDD group L~A~L~A~ \> S/L~g~**z = 3.35** (R).\
Happy faces: MDD group L~A~L~A~ \> ~S/Lg~**z = 2.45** (R)\
^15^**z = 3.40** (L) **z = 2.09** (R)\
^16^Connectivity with ventromedial PFC **z = 2.9** ("Maintain")0%Reward processing16% (22)\
^22^**z = 2.30** (R)0%66% (17, 18, 19, 22)\
^18^**z = 2.40** (L medial frontal gyrus/BA 10)\
^19^Association with anxiety symptoms **B = 4.21**, **p \< .01**\
**^22^z = 2.20** (R ventrolateral OFC), **z = 2.03** (L dorsal OFC)0%16% (18)\
^18^Reward anticipation **z = 2.71** (bilateral), reward outcome **z = 2.32** (bilateral)33% (17, 20)\
^20^**z = 2.47** (L)66% (17, 18, 19, 21)\
^18^Reward anticipation **z = 4.00** (L caudate head) reward outcome **z = 4.05** (L caudate head)\
^19^Association with general clinical severity **B = .26**, **p \< .01**, association with anxiety symptoms **B = − .64**, **p \< .01**\
^21^**z = 2.17** (bilateral caudate body), **z = 1.89** (R caudate head), **z = 2.15** (L)Resting-state50% (23, 25, 27)\
^23^Connectivity with subgenual ACC **z \> 2.3** (bilateral)\
^25^**z = 2.95** (bilateral)\
^27^Connectivity with caudate **z = 4.8**50% (23, 27, 28)\
^23^**z \> 2.3** (bilateral)\
^27^Connectivity with medial PFC **z = 4.6**\
^28^**z = − 5.9** (L)50% (24, 25, 28)\
^24^z **= 2.10** (bilateral)\
^25^**z = 3.42** (bilateral sup OFC) **z = 2.62** (bilateral inf OFC), **z = 2.18** (bilateral medial OFC)\
^28^**z = 5.44** (L vmPFC), **z = 4.99** (L mOFC)66% (23, 25, 27, 28)\
^23^**z \> 2.3** (R)\
^25^**z = 3.01** (bilateral)\
^27^Connectivity with subgenual ACC **z = 4.6**\
(R)\
^28^**z = 4.15** (L)50% (24, 25, 27)\
^24^**z = 3.19** (R)\
^25^**z = 2.14** (bilateral)\
^27^**z = 4.8** (L)10% (25)\
^25^**z = 2.45** (L)33% (24, 27)\
^24^**z = 3.18** (bilateral caudate)\
^27^**z = 4.8** (bilateral caudate body)[^1][^2][^3]Inline Supplementary Table S1

Inline Supplementary Table S1 can be found online at [http://dx.doi.org/10.1016/j.nicl.2013.11.009](10.1016/j.nicl.2013.11.009){#ir0020}.

5. Overall summary & consideration {#s0060}
==================================

In the present article, we have systematically reviewed the available fMRI studies in youth MDD across 5 functional domains of functioning to provide a comprehensive account of the literature to date. Collectively, the literature provides mounting evidence of altered functional activations and connectivity in extended medial prefrontal network regions in youth MDD, including the ACC, ventromedial PFC, OFC, and closely related subcortical areas including the amygdala and striatum in youth MDD ([Fig. 1](#f0005){ref-type="fig"}; also see [Inline Supplementary Table S1](#b0005){ref-type="boxed-text"} in the supplementary material). These reported alterations, which are present during resting-state conditions, tasks of emotional processing, cognitive control, affective cognition and reward-based decision-making were present in medicated and unmedicated patients. Across the 5 reviewed domains, the most consistently implicated areas were the ACC, specifically pregenual and subgenual divisions, the ventromedial PFC and the amygdala. Activity within, and connectivity between these regions also showed associations with clinical measures of depression severity ([@bb0140; @bb0245; @bb0500; @bb0520; @bb0780]), duration of illness ([@bb0410]), rumination scores ([@bb0820]) and cognitive vulnerability ([@bb0815]). Of note, these significant correlations were reported predominantly in the emotion processing and resting-state domains, where the most consistent and robust alterations in activity and connectivity were found. Furthermore, activity in the subgenual ACC and amygdala appears to be responsive to antidepressant treatment in depressed adolescents ([@bb0725]), although these observations require replication. These neural regions, which are implicated in neurobiological models of MDD ([@bb0505; @bb0580; @bb0595; @bb0600]) and have been used as biological targets for clinical interventions in adult patients (including DBS and CBT), could guide future imaging treatment studies of youth MDD.

In the present article, we have systematically reviewed the available fMRI studies in youth MDD across 5 functional domains of functioning to provide a comprehensive account of the literature to date. Collectively, the literature provides mounting evidence of altered functional activations and connectivity in extended medial prefrontal network regions in youth MDD, including the ACC, ventromedial PFC, OFC, and closely related subcortical areas including the amygdala and striatum in youth MDD ([Fig. 1](#f0005){ref-type="fig"}; also see Inline Supplementary Table S1 in the supplementary material). These reported alterations, which are present during resting-state conditions, tasks of emotional processing, cognitive control, affective cognition and reward-based decision-making were present in medicated and unmedicated patients. Across the 5 reviewed domains, the most consistently implicated areas were the ACC, specifically pregenual and subgenual divisions, the ventromedial PFC and the amygdala. Activity within, and connectivity between these regions also showed associations with clinical measures of depression severity ([@bb0140; @bb0245; @bb0500; @bb0520; @bb0780]), duration of illness ([@bb0410]), rumination scores ([@bb0820]) and cognitive vulnerability ([@bb0815]). Of note, these significant correlations were reported predominantly in the emotion processing and resting-state domains, where the most consistent and robust alterations in activity and connectivity were found. Furthermore, activity in the subgenual ACC and amygdala appears to be responsive to antidepressant treatment in depressed adolescents ([@bb0725]), although these observations require replication. These neural regions, which are implicated in neurobiological models of MDD ([@bb0505; @bb0580; @bb0595; @bb0600]) and have been used as biological targets for clinical interventions in adult patients (including DBS and CBT), could guide future imaging treatment studies of youth MDD.

Comparisons to the adult MDD literature revealed the most consistent findings for emotion processing and resting-state functional connectivity studies, with some support for studies using reward-based decision-making tasks. While drawing comparisons to the adult MDD literature are important and useful for delineating common neurobiological mechanisms of the disorder, it is equally important to acknowledge the differences in youth vs. adult MDD, which are to be expected given the rapid neurodevelopment that occurs over the adolescent and early-adulthood years. Inconsistencies between the youth and adult MDD literature were apparent when examining studies of cognitive control and affective cognition. Although some evidence was shown for fronto-cingulate and fronto-parietal lobe abnormalities during "cold" cognitive processes, the directionality of the findings is less consistent in youth compared to adult MDD. For affective cognition, in studies of emotional distraction, the amygdala was the only region that was consistently reported as hyperactive across the youth and adult MDD studies, although the paradigms used in these two ages groups differed. For cognitive reappraisal, the lack of findings during cognitive reappraisal of negative emotional stimuli in youth MDD sits apart from findings in adult MDD, which implicate hyperactive lateral PFC regions. The inconsistencies in the cognitive control studies between the youth and adult MDD literature may be due, in part, to the fact that cognitive deficits emerge and become more severe with recurrent MDD ([@bb0065]), and therefore abnormalities in brain regions subserving cognitive control would be expected more so in older MDD patients compared to patients who have their first episode in early adulthood. This idea is also supported by the lack of behavioral performance differences during tasks of cognitive control in youths with MDD compared to their healthy peers, indicating that cognitive functioning is not yet compromised. Furthermore, cortical maturation of the prefrontal cortex lags behind subcortical/limbic regions implicated in emotion generative and reward processes ([@bb0620]), which may contribute to the inconsistencies in the cognitive control domain ([@bb0620]).

Despite the small number of fMRI studies in youth MDD, the available literature provides evidence of altered activation and connectivity in neural regions implicated in emotion processing and its regulation and self-referential processing, key processes known to be abnormal in affective disorders including depression. Furthermore, comparisons between studies of adolescent-onset MDD with those in early-adulthood MDD revealed similar findings across all 5 domains, implicating similar neural regions. It is interesting to note, however, that of the 8 studies reporting significant associations between clinical measures of depression and brain activity/connectivity, 5 of those studies were in older youth samples, with a mean age \> 18 years old. This observation speaks further to the importance of neurodevelopmental and environmental changes occurring across this age period that may contribute to the clinical manifestation of depressive symptoms that is more apparent in older patients who have had recurrent MDEs. However, due to small sample sizes in the reviewed studies, and an imbalance of the number of studies containing samples with a mean age of \< 18 and \> 18 years old (20 studies and 8 studies respectively), this argument is speculative. While we have provided a supplementary quantitative analysis that shows a pattern of higher z-scores in studies with older youth (i.e., mean age \> 18 years old) compared to younger adolescents, a formal meta-analysis of these studies providing a statistical measure of the effect sizes of the main findings reported, and statistical differences between groups (i.e., younger adolescents vs. older youth) is warranted.

5.1. Future approaches for biomarker research in youth MDD: The extended medial prefrontal cortical network of MDD {#s0065}
------------------------------------------------------------------------------------------------------------------

The current available literature in youth MDD is broadly consistent with a prevailing 'extended medial prefrontal network' neurobiological model of depression (see [Fig. 1](#f0005){ref-type="fig"}). Based largely on functional imaging studies of adult MDD, the extended medial prefrontal network model proposes that MDD is associated with alterations in a medial network consisting of ventrally located medial PFC regions including the ventromedial PFC (encompassing medial portions of BA 10 and caudal portions of the OFC, BA11) and anterior cingulate cortex (pregenual, mid-cingulate and subgenual divisions) together with closely related regions including the striatum, amygdala and thalamus ([@bb0595; @bb0600]). Importantly, areas of the extended medial prefrontal network are implicated in emotional processes including the generation of affect and modulation of autonomic responses associated with emotional stimuli ([@bb0350; @bb0440; @bb0535]; see [@bb0575] for review). These areas also overlap with DMN regions that are implicated in self-referential processes. Furthermore, these areas interact dynamically with 'executive-control' network areas, namely DLPFC and VLPFC together with anatomically connected parietal lobe areas ([@bb0625]), to regulate mood and cognitive functions including the cognitive regulation of emotion.

We propose that, while it is important to interpret the findings of youth MDD within the context of neurobiological models that are founded on adolescent brain development and risk for psychopathology, the extended medial prefrontal model of MDD can also be used as a theoretical framework within which to understand the neuroimaging findings in youth MDD. This model is particularly relevant for understanding alterations of medial prefrontal regions, where the most consistent evidence is shown in youth MDD. The ACC in particular, shows altered resting-state functional connectivity with the amygdala, dorsomedial PFC and executive-control network areas including the DLPFC ([@bb0140; @bb0320; @bb0340; @bb0650]). Altered functional connectivity between the subgenual ACC and dorsomedial PFC may represent a neural basis for depressive rumination and altered self-referential processing in youth MDD. Similarly, we propose that altered connectivity between the subgenual ACC and amygdala together with observations of amygdala hyperactivity during emotional processing tasks may represent heightened emotional reactivity to emotional and social stimuli. In contrast to medial PFC regions, findings from studies of cognitive control in youth MDD less consistently implicate abnormalities in executive control regions compared to adult MDD studies. This is, however, consistent with a model in which alterations in activity of the extended medial frontal network are the primary pathology in depression, and alterations in dorsolateral areas that subserve executive functioning are secondary. Abnormalities in prefrontal regions subserving higher-order executive functions would therefore be more expected in older adults who have experienced recurrent and longer lasting depressive episodes ([@bb0595]). Given that findings in adolescent and youth MDD patients are consistent with an altered extended medial PFC network, a greater emphasis is needed in future task-based studies to focus on medial network regions, by employing paradigms that focus on depression-relevant maladaptive processes that tap into these regions, including self-referential processing, rumination and guilt ([@bb0050; @bb0420; @bb0645; @bb0795]).

There are important limitations of the reviewed studies that need to be addressed. Firstly, although some studies ensured that patients were medication-free, and these were more pronounced in particular domains (e.g., cognitive control, emotion processing), in many of the reviewed studies patients were medicated and therefore the neuroimaging findings were confounded by medication effects. In addition, in many of the reviewed studies, there was a high prevalence of comorbid disorders in depressed patients, particularly anxiety disorders, which makes it difficult to delineate the specificity of the findings to MDD per se. Findings of amygdala hyperactivity in particular, have also been reported in at-risk individuals and in numerous psychiatric illnesses. Amygdala hyperactivity may therefore not be specific to MDD, and rather a neural substrate of trait anxiety predisposing psychiatric illness.

An outstanding issue that has been neglected in the current literature is the effects of pubertal maturation (measured as either pubertal maturation stage or pubertal timing) on the reactivity of neural systems implicated in adolescent MDD. Many of the current studies have recruited depressed patients with wide age-ranges, for example, spanning 8 to 17 years old in the same cohort (see [Table 1](#t0005){ref-type="table"}). While some imaging studies have matched samples on pubertal maturation (i.e., Tanner stage), only 1 study has examined the effects of pubertal maturation (pre/early vs. mid/late groups based on Tanner stage) on depression-related brain activation by examining a group by pubertal maturation interaction ([@bb0255]). This issue is important to address because pubertal processes, particularly early-onset pubertal maturation, have been linked to adolescent MDD ([@bb0015; @bb0300]). As discussed above, the onset of puberty and subsequent rise of pubertal hormones is associated with important neuroendocrine changes that are intricately linked with substantial remodeling of the adolescent brain including development of structural brain networks supporting cognitive--affective processes (e.g., lateral PFC development) (see [@bb0445] for review) and development of neurotransmitter systems (e.g., development of the dopaminergic system) ([@bb0675]). However, what is not known is whether pubertal maturation interacts with neural systems involved in cognitive--affective processes. It has been suggested that altered development of brain regions implicated in emotion regulation (particularly DLPFC and VLPFC and their connections with ventromedial PFC and amygdala) likely contribute to depression ([@bb0080; @bb0145; @bb0205]). Further, there is evidence that emotion regulation processes mediate the link between pubertal maturation and depression ([@bb0120]). A future avenue of research may be to examine brain activity during cognitive--affective processes in early-onset puberty vs. late-onset puberty in adolescent girls to see if there is a moderating effect of puberty on brain activation, and depressive symptoms.

Another limitation inherent in the reviewed studies relates to the 'pooling' together of patients across wide age-ranges. None of the reviewed studies stratified their neuroimaging analyses by age group and thus the imaging findings do not account for the potential effects of different stages of brain maturation and development that occur across adolescence and early adulthood. Future longitudinal neuroimaging studies of young people with MDD are warranted to reflect continuities in brain development across the adolescent period extending into the mid-twenties, through consideration of developmental-stage in study designs.

Future neuroimaging studies also need to shift the focus towards examining adolescents at high-risk for MDD (either defined as having at least one first-degree relative with a diagnosis of MDD, or another risk-factor such as subthreshold depressive symptoms or at-risk temperament), to better understand brain markers of disease susceptibility. While a limitation of the current review is that we did not focus on studies conducted in adolescents and young people at-risk for MDD, it is an area that warrants further research. Recent evidence from fMRI as well as Diffusion Tensor Imaging (DTI) studies in adolescents and young people at-risk for MDD (based on positive family history) provide compelling evidence of altered fronto-limbic responses to emotional stimuli ([@bb0480; @bb0525]), altered putamen and insula activation during reward anticipation ([@bb0310]) and white matter deficits ([@bb0385]). Thus future studies in at-risk adolescents and youth, compared at different developmental stages in the context of emotion processing and resting-state study contexts will represent significant advances towards biomarker identification.

Furthermore, future imaging studies of youth MDD should endeavor to utilize paradigms that assess other symptoms and features of the disorder, such as excessive experiences of moral emotions including guilt and shame ([@bb0605]), and increased susceptibility to negative emotions resulting from social rejection or exclusion ([@bb0490]). It will also be of interest for future neuroimaging studies to examine brain activity related to guilt, shame and other ruminative thought processes in the context of treatments such as CBT and other mindfulness-based techniques. Such treatments are used to treat patients with chronic, recurrent depression, and may prove to be effective for treating the disorder in young people.

Finally, while the available literature can usefully guide future research into the pathophysiology of youth MDD, the clinical utility of the findings is equally important. It is hoped that in the future imaging findings may assist 'real world' clinical decision-making by, for example, identifying neural activation patterns that predict treatment response at the individual-level. For example CBT, which exerts its clinical efficacy in depression by enhancing putative cognitive regulatory strategies (including reappraisal processes), is currently recommended as first-line treatment for youth MDD. Yet, there is an absence of good CBT-focused imaging studies in youth MDD. Given evidence in the adult MDD literature for a role of the pregenual ACC and amygdala in predicting treatment response to CBT, and the clinical implications of identifying such biomarkers that can distinguish between responders and non-responders to treatment, future treatment studies employing functional MRI in the context of randomized clinical trials will be important for ultimately testing the prognostic utility of fMRI.

5.2. Concluding remarks {#s0070}
-----------------------

The field of neuroimaging in youth MDD is a burgeoning area of research, however it is still in its infancy. To date, 28 neuroimaging studies utilizing fMRI have been conducted in youth (adolescent and young adult) patients (\< 25 years of age) with MDD. These studies overwhelmingly implicate abnormalities in the extended medial network in youth MDD, with robust findings in the ACC and amygdala. Moreover, there is some evidence for brain biomarkers of treatment response, which remains a promising avenue of future research, particularly in emotion processing and resting-state study contexts. In contrast, cognitive control deficits are less pronounced in youth MDD and are not as strongly supported by studies in adult MDD. Studies of affective cognition are only beginning to emerge and thus inferences about the similarities and differences to the adult MDD literature are too premature to make. Future longitudinal studies examining the effects of neurodevelopmental changes and pubertal maturation on brain systems implicated in reward and cognitive--affective processes will be pivotal for advancing our understanding of the illness. As the field of youth psychiatry continues to work towards better clinical treatment and management of youth MDD, neuroimaging studies employing fMRI-based approaches in the context of treatment studies will be equally important to identify biological markers of the illness that may have power in predicting treatment response, and ultimately illness recovery.
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Task-based functional connectivity analyses are often used to complement the conventional assessment of brain activations/deactivations. Such analyses are geared towards assessing changes in the strength of correlated activity among certain brain regions of interest when comparing different task conditions. As such they are typically performed on (and informed by) the same experimental data that was used to assess activations/deactivations.

Resting-state functional connectivity studies are instead based on the collection of fMRI/BOLD signal time-series in the absence of any task demands (e.g., subjects laying quietly in the scanner over a duration of several minutes with their eyes closed). The analysis of these data can take several forms, but all exploit the fact that brain regions with strong anatomical connections typically show organized spontaneous correlations in their functional activity over time (e.g., minutes).

![The extended medial prefrontal network of youth MDD. Shown are brain regions most consistently implicated in fMRI studies of adolescent and youth MDD across 5 domains of functioning. The center panel shows the 'hub' of the extended medial network, comprising the anterior cingulate (pregenual, mid-cingulate and subgenual cingulate cortices) and posterior cingulate cortices, and ventromedial prefrontal cortex encompassing medial portions of BA 10 and caudal portions of orbitofrontal cortex/BA 11. Left panel: Cortical regions of the extended medial prefrontal network showing dorsolateral prefrontal cortex (top) and the medial and lateral portions of the orbitofrontal cortex (bottom). Right panel: Coronal slices showing subcortical regions including the amygdala (top) and striatum (bottom). The coronal slice of the striatum (MNI coordinate y = 12 mm) shows the dorsal caudate, and the dorsal and ventral divisions of the putamen.](gr1){#f0005}

###### 

Overview of the 28 fMRI studies identified in youth MDD.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors (publication, year)     Sample size                                            Age range               Mean age (SD)           Axis 1 diagnosis/comorbid illnesses                                                                                                                                                                                        First episode           Mean duration of illness/MDE         Medication status                                                                                                                                         Imaging modality                                                                               Analysis (ROI, whole-brain)                                                                                                                                                                                                                    Task(s)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Significant findings
  ------------------------------- ------------------------------------------------------ ----------------------- ----------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------- ------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Emotion processing studies*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  1\. [@bb0730]                   5 MDD\                                                 8--16                   12.3 (2.7)\             Primary diagnosis of GAD. Separate sample of girls with primary diagnosis of MDD (n = 5). 2 of MDD patients had comorbid GAD                                                                                               Not reported            Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           Whole-brain                                                                                                                                                                                                                                    Passive viewing task with fearful and neutral Ekman faces. No overt responses required, children instructed to focus centrally and get an overall sense of the faces.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      MDD \< HC and GAD in L amygdala to fearful faces (vs. fixation cross).\
                                  12 GAD\                                                                        12.8 (2.1)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        n.s. in right amygdala for fearful faces (vs. neutral faces or fixation).
                                  12 HC                                                                          12.2 (2.6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  2\. [@bb0500]                   15 MDD\                                                19--30                  24.5 (5.5)\             MDD. 46.6% patients had co-morbid (past, not current) depressive &/or anxiety disorders: dysthymia (3), PTSD (2), GAD and panic disorder (1), dysthymia and panic disorder (1)                                             Not reported            Not reported                         All medication-free                                                                                                                                       fMRI and FC                                                                                    ROI-bilateral extended amygdala. Used as seed-region in FC analyses                                                                                                                                                                            Hariri face-matching task with fearful, happy and angry faces. Sensiromotor control condition. Participants instructed to match by emotional expression, 1 of 2 visually presented probe faces to a target face via button press.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          fMRI findings: MDD \> HC in bilateral extended amygdala to all emotional faces during face-matching (vs. control) condition.\
                                  16 HC                                                                          24.3 (5.0)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         FC findings: MDD \> HC connectivity between bilateral extended amygdala and subgenual ACC but reduced connectivity between extended amygdala and pregenual ACC.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Negative correlation between BDI-2 scores and FC between extended amygdala and pregenual ACC such that higher BDI-2 scores were associated with weaker connectivity.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    n.s. correlation between symptom severity and strength of extended amygdala-subgenual connectivity.

  3\. [@bb0785]                   12 MDD\                                                13--17                  15.9 (1.4)\             MDD. No current comorbid Axis 1 disorders                                                                                                                                                                                  Yes                     Diagnosed for study                  All medication-free                                                                                                                                       fMRI                                                                                           ROI-bilateral amygdala\                                                                                                                                                                                                                        Hariri face-matching task with fearful, happy and angry faces. Sensiromotor control condition. Instructions as above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      MDD \> HC in L amygdala and bilateral ACC to all emotional faces during face-matching (vs. control) condition.\
                                  12 HC                                                                          15.4 (1.7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Whole-brain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               n.s. group × emotion interaction.

  4\. [@bb0815]                   29 MDD\                                                18--22                  20.4 (1.8)\             MDD. No current comorbid Axis 1 disorders                                                                                                                                                                                  Yes                     Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           ROI-bilateral amygdala\                                                                                                                                                                                                                        Hariri face-matching task with fearful and angry faces. Sensorimotor control condition. Instructions as above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             MDD \> HC in L amygdala and bilateral insula to all emotional faces during face-matching (vs. control) condition.\
                                  26 'at-risk' for MDD\                                                          20.6 (0.9)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Whole-brain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               MDD \< HC L DLPFC (BA 8, 47) to all emotional faces (vs. control) condition.\
                                  31 HC                                                                          20.8 (1.5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         MDD \> 'at-risk' group: medial, middle and superior frontal gyri (SFG) to all emotional faces (vs. control) condition. Positive correlation between CSQ scores (measuring cognitive vulnerability) and L amygdala responsiveness to emotional faces in all subjects, controlling for CES-D scores.

  5\. [@bb0520]                   27 MDD\                                                17--24                  20.4 (1.9)\             MDD. No current comorbid Axis 1 disorders                                                                                                                                                                                  Yes                     Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           ROI-bilateral amygdala\                                                                                                                                                                                                                        Hariri face-matching task with fearful and angry faces. Sensorimotor control condition. Instructions as above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             MDD \> HC in L amygdala to emotional faces during face-matching (vs. control) condition.\
                                  25 HC                                                                          20.9 (1.5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Whole-brain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Positive correlation between bilateral amygdala activation and CES-D scores in MDD patients.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Whole brain findings: MDD \> HC in L MFG (BA 9), L STG (BA 22), L ITG (BA 20) and L thalamus\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    MDD \< HC in right SFG (BA 10).

  6\. [@bb0725]^a^                15 MDD\                                                11--18                  14.2 (1.9)\             MDD. 31.6% comorbid anxiety, 10.5% ADHD                                                                                                                                                                                    68.4% 1st-episode\      19.2 ± 19.5 months                   Treatment (open label) study. MDD patients assigned to 8-week FLX treatment and continued treatment. Patients could not receive CBT while on medication   fMRI                                                                                           ROI-bilateral amygdala, orbitofrontal cortex (OFC), subgenual ACC\                                                                                                                                                                             Gender discrimination task with fearful and neutral Ekman faces. Participants need to select the gender of each face and ignore the emotional content.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Baseline: MDD \> HC in bilateral frontal lobe, temporal lobe, putamen, insula, R amygdala and hippocampus. Following 8-week treatment with FLX: no significant between group differences in amygdala activity for fearful vs. neutral contrast (i.e., activity normalized). For the OFC, MDD adolescents had greater L and R OFC activity at baseline but not week 8 that approached significance for R but not L OFC. For the subgenual ACC, at baseline MDD adolescents had greater activation in L and R subgenual ACC which normalized by week 8. The magnitude of effect approached significance for R but not L subgenual ACC.
                                  17 HC                                                                          14.9 (2.5)                                                                                                                                                                                                                                         26.3% 2nd episode\                                                                                                                                                                                                                                                                                                    Whole-brain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                    5.3% 3rd episode                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  *Cognitive control studies*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  7\. [@bb0335]                   21 MDD\                                                14--17                  16.2 (.8)\              MDD. No current comorbid Axis 1 disorders                                                                                                                                                                                  Yes                     Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           Whole-brain                                                                                                                                                                                                                                    3 tasks to assess executive function: Simon task (interference inhibition and selective attention), Stop task (response inhibition) and Switch task (cognitive flexibility/attentional set shifting).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      MDD \< HC in lateral PFC regions (DLPFC, VLPFC), ACG, insula, occipital and parietal lobe areas during all 3 tasks.\
                                  21 HC                                                                          16.3 (1.1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         No sex × group interactions were observed.

  8\. [@bb0780]                   13 MDD\                                                13--17                  16.0 (1.5)\             MDD. No current comorbid Axis 1 disorders                                                                                                                                                                                  Not reported            Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           Whole-brain                                                                                                                                                                                                                                    Stop-signal task with "X" and "O" visual stimuli paired with an auditory tone. Participants were asked to press a button as quickly as possible whenever they see the letter "X" or "O" but to inhibit their motor response when an auditory tone is delivered ("stop" trials). Inhibition is measured by comparing neural responses to all stop trials vs. go trials.                                                                                                                                                                                                                                                                                                                                                                     MDD \> HC in a large cluster localized to subgenual ACC, extending into pregenual ACC during all-stop vs. no-stop condition.\
                                  13 HC                                                                          15.8 (1.5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         MDD \< HC in medial frontal gyrus and visual cortex.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Greater subgenual ACC activation associated with higher CDRS-R scores, indicating greater depressive symptoms. In contrast, greater bilateral task-related medial frontal gyrus activation associated with lower scores on the CDRS-R.

  9\. [@bb0560]                   15 MDD suicide attempters (ATT)\                       13--17                  16.2 (0.8)\             MDD. Patients were excluded if they had current/life-time Hx of bipolar disorder or psychosis                                                                                                                              Not reported            Not reported                         10 ATT and 7 NAT on AD                                                                                                                                    fMRI                                                                                           Whole-brain                                                                                                                                                                                                                                    Go/No-Go task. Participants presented with stimuli (letters) and are instructed to respond, via button press, to visually presented letters ("Go" condition; 75% of trials) and to inhibit responses to the "No-Go" trials (letter "V"). Blocks are interleaved with rest condition (fixation cross). Response inhibition measured by comparing neural responses to "No-Go" trial following a "Go" trial.                                                                                                                                                                                                                                                                                                                                  NAT \> HC in L insula during response inhibition (during Go/No-Go trials.)\
                                  15 MDD non-attempters (NAT)\                                                   15.9 (1.5)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        NAT \> ATT in R ACC. ATT group did not show the expected activation differences compared to HC during the Go/No-Go trials.\
                                  14 HC                                                                          15.2 (1.4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         No significant correlations between brain regions that emerged from the 3 × 2 interaction and anxiety, depression, medication status, gender, or pubertal status.

  10\. [@bb0095]                  20 MDD\                                                13--18                  16.2 (.8)\              MDD. No current comorbid Axis 1 disorders                                                                                                                                                                                  Yes                     Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           Whole-brain                                                                                                                                                                                                                                    Continuous Performance Task (CPT) measuring selective and sustained attention. Participants are instructed to detect and respond to infrequent targets (letters X and O) that are embedded in highly frequent non-targets (letters A--N). For every 3 correct responses made for the 'rewarded' letter, the participant earns 1 lb and one of 2 color bars (blue/red) rises. For every 3 correct responses for the 'non-rewarded' target letter, the color bar still rises but no monetary reward is given. To measure brain activation associated with "sustained attention" the contrast was: non-reward target vs. non-target. For brain activation associated with "reward" the contrast was: reward targets vs. non-reward targets.   For sustained attention: within-group analyses revealed activation of bilateral cerebellum, inferior temporal, parietal and occipital cortices. MDD showed additional activation in DLPFC and medial PFC. HC \> MDD in cluster localized to occipital cortex extending into left precuneus. No areas were activated more in MDD group compared to HC.\
                                  21 HC                                                                          16.3 (1.1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         For reward, HC \> MDD in R IFC, ACC, thalamus, caudate and putamen, R hippocampal and middle temporal gyri. Depression scores on a CBCL scale correlated negatively with activation in the hippocampus/temporal lobe cluster.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Cerebellum activation correlated with activation in the IFC/ACC across all subjects in the depressed group, reflected as compensatory response for reduced frontal lobe activation.

  11\. [@bb0140]^b^               18 MDD\                                                15--24                  18.9 (2.2)\             MDD. 33.3% comorbid anxiety                                                                                                                                                                                                50% first-episode       median length of MDE = 10.5 months   9 patients on AD                                                                                                                                          fMRI (task) and resting-state FC                                                               Whole-brain (task-based activity)\                                                                                                                                                                                                             Multi-source interference task (MSIT) used to examine response inhibition. Participants need to respond to the identity (numerical value, not position of) visually presented target numbers in a 3 digit sequence that corresponded to button box responses (index finger for '1', middle for '2' and ring finger for '3'. Congruent and incongruent trials (see paper for extra detail). The main focus of study was to look at how FC in the subgenual ACC changed between resting-state periods (expected activation) and performance of the incongruent MSIT condition (i.e., expected deactivation).                                                                                                                                 MSIT associated with robust activation in frontoparietal areas (see paper for extra detail).\
                                  19 HC                                                                          19.9 (2.7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Subgenual ACC as seed region in\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          fMRI findings: n.s. between-group differences in activation.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          FC analyses                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               FC findings for subgenual ACC: HC participants showed task-related decreases in connectivity between the subgenual ACC and right ventral caudate/nucleus accumbens. MDD patients showed greater connectivity between subgenual ACC and ventromedial PFC at rest compared to task-performance.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  *Affective cognition studies*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  12\. [@bb0615]^b^               10 MDD\                                                9--16                   13.8 (2.7)\             MDD. 40% comorbid anxiety disorder                                                                                                                                                                                         Not reported            Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           ROI-bilateral amygdala\                                                                                                                                                                                                                        Cognitive--affective task as in [@bb0045] with encoding and recognition memory phase. Encoding phase: Participants view and rate face stimuli as below in [@bb0045]. Recognition phase: participants are shown 24 of the same actors as in the encoding phase and 24 new actors and have to identify if they had previously seen the actor.                                                                                                                                                                                                                                                                                                                                                                                                MDD \> HC in amygdala for "all faces remembered" vs. "all forgotten". No main effect of emotion (angry, fearful, happy, neutral) on amygdala activation when collapsed across both memory conditions. Final whole-brain analysis of the entire sample for successful vs. unsuccessful encoding (collapsed across all emotions) revealed activations in the middle frontal gyrus extending into the orbitofrontal cortex, and left medial temporal lobe.
                                  11 anxiety disorders\                                                          11.5 (1.5)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Whole-brain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                  23 HC                                                                          14.8 (2.2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  13\. [@bb0045]^b^               26 MDD w/wo anxiety disorders (MDD only n = 12)\       11--16                  14.1 (2.2)\             MDD 'only' sample---no comorbid anxiety disorders                                                                                                                                                                          Not reported            Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           ROI-bilateral amygdala, OFC (medial and lateral)                                                                                                                                                                                               Cognitive--affective task examining attentional modulation of emotion. Participants view faces (neutral, fear, angry and happy) and are instructed to either pay attention to the face by rating the face stimuli on 5-point scales (1 not at all; 5 very): "How hostile is this face?" "How afraid are you of this face?" and "How wide is the nose?". On 4th block, participants "passively" viewed faces (unconstrained attention).                                                                                                                                                                                                                                                                                                     Fearful face viewing: Sig group × attention--condition interaction in bilateral amygdala. Post-hoc t-tests for fearful-afraid (rating) vs. fearful-passive showed between group differences in L amygdala. MDD patients showed greater amygdala activity compared to healthy controls both when patients with comorbid anxiety were included and excluded. Passive viewing: Sig group × face-emotion interactions in bilateral amygdala. Post-hoc t-tests for fearful passive vs. happy passive revealed greater amygdala activation in anxious group vs. HC. MDD (with and without comorbid anxiety) showed deactivation of amygdala response to fearful vs. happy faces. OFC activation during fearful face viewing: MDD \> HC (trend effect but not significant). OFC activation during passive viewing: anxiety group \> HC and MDD for the contrast fearful passive-happy passive (when MDD patients with comorbid anxiety were included and excluded).
                                  16 anxiety disorders\                                                          12.7 (1.8)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                  45 HC                                                                          13.9 (2.2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  14\. [@bb0455]^b^               31 MDD and anxiety disorder patients (MDD only = 6)\   11--16                  13.5 (2.3)\             MDD and anxiety disorders. 13 patients had MDD with comorbid anxiety disorders (separation anxiety, GAD). 6 MDD 'only'. Remaining patients had mixed anxiety disorders (social phobia, separation anxiety disorder, GAD)   Not reported            Not reported                         All medication-free                                                                                                                                       fMRI + genotyping of serotonin transporter alleles (S and L~G~ carriers vs. L~A~ homozygotes   ROI-bilateral amygdala                                                                                                                                                                                                                         Task as in [@bb0045]. Analyses focused on the amygdala response for the "how afraid" (vs. fixation) condition only, for each of the emotions (angry, fearful, happy and neutral).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Significant genotype × diagnosis × facial emotion interaction characterized fearful and happy faces and findings were opposite in MDD group compared to HC group. In MDD group, finding of greater amygdala activity occurred in L~A~L~A~ individuals than S/L~G~ carriers (opposite to HC group). Weaker findings for happy faces; interaction was driven from patient group only, where L~A~L~A~ individuals showed more amygdala activity than S/L~G~ carriers. Amygdala activation to fearful faces during afraid ratings was modulated by genotype.
                                  33 HC                                                                          13.7 (2.7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  15\. [@bb0460]^b^               27 MDD and anxiety patients\                           9--18                   13.4 (2.3)\             MDD and anxiety disorders. 13 had MDD with comorbid anxiety disorders (as above), 5 had MDD 'only'. Remaining patients had mixed anxiety disorders (as above)                                                              Not reported            Not reported                         All medication-free                                                                                                                                       fMRI + genotyping of BDNF gene polymorphisms (Val/Met carriers vs. Val/Val homozygotes)        ROI-amygdala and anterior hippocampus                                                                                                                                                                                                          As above in [@bb0455] except analyses were focused on the amygdala and anterior hippocampus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Significant genotype x diagnosis interaction (no effects of emotion). Met carriers \> Val homozygote carriers in bilateral anterior hippocampus and amygdala during "how afraid" ratings of all faces irrespective of emotion.
                                  31 HC                                                                          13.7 (2.6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  16\. [@bb0570]                  14 MDD\                                                13--17                  15.7 (1.5)\             MDD. No current comorbid Axis 1 disorders                                                                                                                                                                                  Not reported            Not reported                         All medication-free                                                                                                                                       fMRI (task) and resting-state FC                                                               ROI-bilateral amygdala. Used as seed region in FC analyses                                                                                                                                                                                     Cognitive reappraisal task consisting of 2 conditions: "Reduce" and "Maintain". Picture stimuli are negative images taken from IAPS with ratings between 2 and 3.5 on valence and 5--7 on arousal. During "maintain" condition, participants are instructed to look at the picture and maintain any emotion they feel towards the picture. On "reduce" trials, participants have to use cognitive reappraisal techniques to effectively reduce the negative affect they associate with the stimulus. At the end of each block, participants rate how negative they feel on a scale from 1 to 4.                                                                                                                                            fMRI findings: n.s. between group differences in activation during reappraisal of negative images (reappraise negative--maintain negative condition). No differences in subjective ratings of reappraisal success.\
                                  14 HC                                                                          15.1 (1.6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         FC findings: MDD \< HC in amygdala-medial PFC and amygdala insula connectivity during "Maintain" condition.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    MDD \> HC in amygdala-medial PFC connectivity during "Reduce" condition.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  *Reward processing studies*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  17\. [@bb0245]                  14 MDD\                                                9--17                   14.6 (1.6)\             MDD. Comorbid disorders: dysthymia (2), GAD (10), social phobia (5), panic disorder (1), and separation anxiety disorder (1)                                                                                               Not reported            Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           ROI-bilateral ACC (BA 32, 24), amygdala, caudate, inferior, middle, superior, and medial OFC                                                                                                                                                   Reward processing task with decision making/anticipation phase and outcome phase. Participant chooses between constant or varying magnitude and probability of rewards. 4 trial types: high probability/high magnitude, high probability/low magnitude, low probability/high magnitude, low probability/low magnitude.                                                                                                                                                                                                                                                                                                                                                                                                                     Decision making phase: MDD \> HC in L superior OFC. MDD \< HC in bilateral caudate and R inferior OFC, especially during high-magnitude reward conditions.\
                                  17 HC                                                                          14.4 (1.8)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Outcome phase: MDD \< HC in the ACC, amygdala, R and mid superior OFC regions to small compared to large wins or losses. Amygdala hyperactivation to large wins.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Direction of OFC activation in MDD patients during outcome phase dependent on magnitude of reward.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    In decision phase: correlation between depression severity and amygdala and R inferior OFC activity in MDD patients. In outcome phase: correlations with ACC, L amygdala and bilateral caudate in MDD patients.

  18\. [@bb0255]^b^               15 MDD\                                                8--17                   13.5 (2.1)\             MDD. Comorbid disorders: GAD (8), social anxiety (3), panic disorder (1)                                                                                                                                                   Not reported            Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           ROI-striatum encompassing bilateral ventral striatum and caudate (head, body, tail), and 'PFC' region encompassing medial regions (BA 24, 25, 32, 10, 11) and lateral (BA 9) areas                                                             Guessing card task with monetary reward. Participants have to guess (through button press) whether the value of a visually presented card with a possible value of 1--9 is higher or lower than 5. This is followed by an anticipation phase, after which the value of the card is presented and feedback is given (win, loss or neutral).                                                                                                                                                                                                                                                                                                                                                                                                 Reward anticipation and outcome: MDD \< HC in bilateral caudate. MDD \> HC in DLPFC. MDD also showed greater activation in medial PFC (BA 10) during reward outcome only.\
                                  28 HC                                                                          13.1 (2.6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         After adjusting for differences in pubertal maturation, findings in caudate remained significant. Findings in DLPFC remained evident only within the mid/late developmental group.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sex and age accounted for a large amount of variance in real-world positive affect.

  19\. [@bb0260]^a^               13 MDD                                                 10--16                  12.9 (2.3)              MDD. Comorbid disorders: GAD (10). Of the 10 with MDD and GAD 3 also had separation anxiety disorder, 1 had social phobia, 1 had panic disorder and 1 had both social phobia and panic disorder                            Not reported            Not reported                         Treatment (open-label) study. Patients assigned to 8-week treatment with FLX or citalopram + CBT or CBT alone                                             fMRI                                                                                           ROI-striatum as in [@bb0255] and medial PFC (BA 32 and medial areas BA 9 and 10)\                                                                                                                                                              Guessing card task as above in [@bb0255]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CBT + medication (vs. CBT alone) associated with lower depressive and anxiety symptoms at discharge. Baseline striatal and medial PFC activities were predictors of treatment response: final general clinical severity was associated with striatal reactivity during reward outcome.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Changes in symptoms and rate of symptom change/reduction over time were analyzed using a growth curve model to produce two variables (intercept and slope) respectively                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Greater striatal reactivity during reward anticipation was associated with faster rate of anxiety symptom decline; conversely greater medial PFC activity during reward anticipation associated with a slower rate of decline in anxiety symptoms.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    No significant findings with depression scores. No associations with neural activity during outcome of reward.

  20\. [@bb0135]                  19 MDD\                                                15--24                  18.6 (2.2)\             MDD. 29.4% comorbid anxiety                                                                                                                                                                                                52.9% first-episode     Median length of MDE = 9 months      9 patients on AD                                                                                                                                          fMRI                                                                                           ROI-bilateral amygdala\                                                                                                                                                                                                                        Social feedback task during which participants receive social feedback from people (faces) they believe were evaluating them. Participants are presented with photographs of faces ('positive feedback' faces and control faces) and post-scan had to rate on a scale (1--9) how good it made them feel to discover those people (positive feedback faces) "liked" them.                                                                                                                                                                                                                                                                                                                                                                   MDD \> HC in bilateral amygdala during positive feedback (vs. control) condition.\
                                  20 HC                                                                          19.3 (2.9)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Whole-brain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               MDD \> HC in ventrolateral PFC, pregenual ACC and anterior insular cortex during processing of faces in general (irrespective of feedback).

  21\. [@bb0555]^b^               10 MDD\                                                8--16                   13.31 (2.49)            MDD. Comorbid disorders: GAD (9). Of the 9 with MDD and GAD 3 also had social phobia, and 1 had panic disorder                                                                                                             Not reported            Not reported                         All medication-free                                                                                                                                       fMRI                                                                                           ROI-striatum encompassing bilateral caudate (head, body, tail) and putamen                                                                                                                                                                     Guessing card task as above in [@bb0255]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   MDD \< HC in caudate during reward anticipation following a win (positive feedback). n.s. between group differences for reward anticipation following a loss, non-win and non-loss.
                                  16 HC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  22\. [@bb0630]                  22 MDD\                                                12--20                  15.0 (2.1)\             MDD. 5 patients had comorbid anxiety disorders including anxiety and ADHD                                                                                                                                                  Not reported            Not reported                         Not reported                                                                                                                                              fMRI                                                                                           ROI-dorsal ACC (BA 24, 32), OFC (BA 11, 47), mPFC (BA 8, 10)\                                                                                                                                                                                  Wheel of Fortune (WOF) task, a monetary, two-choice task that allows for the separate examination of reward selection, anticipation and outcome. 3 wheels are presented that are divided into different slices and colors representing the probability of winning (25% vs. 75%) and magnitude (\$6 or \$3 vs. \$2 or \$1) of reward.                                                                                                                                                                                                                                                                                                                                                                                                       For high risk (25% chance event) vs. equal risk (50/50), HC \> MDD in the R ventrolateral OFC. MDD \> HC in the R caudal and L dorsal OFC.\
                                  22 HC                                                                          16.0 (2.1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Whole-brain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               n.s. between group differences for risk/reward (25/75) vs. control. Correlations between functional ROIs and risk-related behavior showed the proportion of high-risk (25% chance probability) behavior correlated negatively with BOLD signal change in L ACC and R ACC in healthy controls.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  *Resting-state studies*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  23\. [@bb0125]                  12 MDD\                                                15--19                  16.5 (0.9)\             MDD. Comorbid disorders: GAD (7), Social Phobia (3), PTSD (2) and ADHD (3)                                                                                                                                                 No                      26.5 ± 25.9 months                   10 patients on AD, antipsychotics and stimulants                                                                                                          fMRI resting-state FC                                                                          FC "seed-based" analyses. Seed regions included bilateral (seed in R and L) subgenual ACC (BA 25), amygdala and supragenual ACC (BA 32)                                                                                                        N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        MDD group showed reduced FC between subgenual ACC and several regions including the supragenual ACC, R medial frontal cortex (BA 10), L IFC (BA 47) and insular cortex. n.s. differences in amygdala or supragenual ACC seeds.\
                                  14 HC                                                                          16.8 (1.5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         No correlations between FC and symptom severity scores on BDI, duration of illness, medication status or presence of anxiety disorder.

  24\. [@bb0405]                  18 MDD\                                                13--17                  15.8 (1.2)\             MDD. 58.8% comorbid anxiety disorder                                                                                                                                                                                       Yes                     \> 6 months                          All medication-free                                                                                                                                       fMRI resting-state                                                                             Analysis of resting state activations using ALFF approach. ALFF values for frontal lobe ROIs and subcortical/paralimbic ROIs were averaged within each group to create a "frontal ALFF" and "subcortical/paralimbic" ALFF value respectively   N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        MDD \> HC ALFF in 5 regions: R DLPFC, bilateral IFG and within the IFG at the triangular region and orbital region.\
                                  18 HC                                                                          16.2 (0.9)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         MDD \< HC ALFF In subcortical regions including the L insular, bilateral caudate, and left hippocampus. Mean values of "frontal" ALFF demonstrated sig higher values than "para-limbic" ALFF in both MDD and HC groups. Sig between-group difference revealed increased frontal lobe ALFF and concurrent decreased subcortical/para-limbic ALFF in MDD. This was interpreted to reflect an imbalance.

  25\. [@bb0410]                  16 MDD\                                                15--18                  17.1 (1.3)\             MDD. No current comorbid Axis 1 disorders                                                                                                                                                                                  Yes                     5.02 ± 1.4 months                    All medication-free                                                                                                                                       fMRI resting-state FC                                                                          FC using GTA based on small-world networks of the brain where brain networks are represented graphically as nodes connected by edges                                                                                                           N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        MDD showed higher resting-state connectivity in resting-state networks compared to HC. Regions included were: ACC, DLPFC, medial and inferior prefrontal cortex, insula, amygdala and temporal cortices. Disrupted small-world properties found in amygdala and PFC-related connections in MDD, reflecting impaired organization and efficiency Connections between the amygdala and temporal cortices, amygdala-precentral cortex, amygdala-postcentral cortex and prefrontal-inferior parietal lobe correlated positively with duration of illness in MDD patients.
                                  16 HC                                                                          17.3 (1.5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  26\. [@bb0330]                  17 MDD\                                                18--43                  26.5 (7.7)\             MDD. No current comorbid Axis 1 disorders                                                                                                                                                                                  Yes                     2.59 ± 1.33 months                   Treatment study. MDD patients assigned to 6 week treatment with an SSRI, SNRI or TCA                                                                      fMRI resting-state (baseline only)                                                             ReHo---provides a measure of intra-regional activity fluctuations between an index voxel and its neighboring voxels                                                                                                                            N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        MDD \< HC ReHo in L cerebellum posterior lobe, R fusiform gyrus, L parahippocampal gyrus, and the R postcentral gyrus.\
                                  17 HC                                                                          24.2 (4.4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         MDD \> HC ReHo in R ITG.

  27\. [@bb0150]^b^               As in [@bb0150] above                                  As in [@bb0150] above   As in [@bb0150] above   As in [@bb0150] above                                                                                                                                                                                                      As in [@bb0150] above   As in [@bb0150] above                As in [@bb0150] above                                                                                                                                     fMRI resting-state FC                                                                          FC "seed-based" analyses. Seed region was focused on cingulate sub-regions (subgenual ACC, pregenual ACC, anterior mid-cingulate and posterior mid-cingulate (MCC)                                                                             N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3 main findings: 1) MDD \> HC in connectivity between the subgenual ACC and dorsomedial PFC; 2) MDD \> HC in connectivity between the pregenual ACC and left DLPFC; and 3) MDD \<  HC in connectivity between the pregenual ACC and caudate nucleus body bilaterally.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Positive correlation between BDI scores and connectivity strength between the subgenual ACC and dorsomedial PFC. Negative correlation between depression severity and connectivity between anterior MCC and left dorsal caudate nucleus.

  28\. [@bb0820]                  32 MDD\                                                18--22                  20.53 (1.8)\            MDD. No current comorbid Axis 1 disorders                                                                                                                                                                                  Yes                     10.53 ± 7.10 months                  All medication-free                                                                                                                                       fMRI resting-state FC                                                                          ICA-data driven approach used to measure FC across maximally spatially independent networks (components) of coherently activated voxels. ICA used to identify the DMN                                                                          N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        MDD \> HC ICA (connectivity) in dorsal mPFC/ventral ACC, ventral mPFC and medial orbital PFC.\
                                  33 HC                                                                          20.3 (1.6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         MDD \< HC in posterior cingulate cortex (PCC)/precuneus, R angular gyrus (AG), and L AG/precuneus.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    In MDD group, increased FC in anterior medial cortex correlated positively with rumination score, while decreased FC in posterior medial cortex correlated negatively with autobiographical memory.
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: ^a^Treatment study. ^b^Denotes overlapping samples. *Abbreviations*: MDD: major depressive disorder; GAD: generalized anxiety disorder; ADHD: attention deficit hyperactivity disorder; ATT: suicide attempters; NAT: non-suicide attempters; HC: healthy controls; SD: standard deviation; MDE: major depressive episode; fMRI: functional magnetic resonance imaging; FC: functional connectivity; ROI: region of interest; ALFF: amplitude of low frequency fluctuation; GTA: graph theory analysis; ReHo: regional homogeneity; ICA: independent component analysis; ACC: anterior cingulate cortex; DLPFC: dorsolateral prefrontal cortex; MFG: middle frontal gyrus; STG: superior temporal gyrus; ITG: inferior temporal gyrus; SFG: superior frontal gyrus; OFC: orbitofrontal cortex; ACG: anterior cingulate gyrus; IFC: inferior frontal cortex; IFG: inferior frontal gyrus; DMN: default mode network; BDNF: brain derived neurotrophic factor; FLX: fluoxetine; CBT: cognitive behavioral therapy; AD: antidepressant; SSRI: selective serotonin reuptake inhibitor; SNRI: serotonin noradrenaline reuptake inhibitor; TCA: tricyclic antidepressant; BDI: Beck Depression Inventory; BDI-2: Beck Depression Inventory-II; CSQ: client satisfaction questionnaire; CES-D: center for epidemiologic studies depression scale; CDRS-R: children\'s depression rating scale revised; CBCL: child behavior checklist.

[^1]: Note: z-scores were not calculated for 3 studies (1, 2 and 17) due to a lack of information. Where T statistics and F statistics were reported, z-scores were calculated using standard SPM and Matlab scripts for conversion into 1-tailed z-scores. For studies where only p values were reported, the p values were converted into their standardized z-score. Where bilateral clusters were reported for the same neural region, an average z-score for the left and right cluster is reported. Similarly, where multiple clusters of activation were reported for the same neural region, an average z-score for the neural region is reported.

[^2]: Approached significance.

[^3]: Maxima of the cluster did not originate in the OFC.
